ARCHIVED — Vol. 149, No. 9 — February 28, 2015

Warning This Web page has been archived on the Web.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

GOVERNMENT NOTICES

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice respecting the Canada-Ontario Agreement on Great Lakes Water Quality and Ecosystem Health

Notice is hereby given that the Minister of the Environment (“the Minister”) has entered into the Canada-Ontario Agreement on Great Lakes Water Quality and Ecosystem Health, 2014 (“the COA”). The Minister is publishing the Agreement in accordance with subsection 9(6) of the Canadian Environmental Protection Act, 1999 (S.C. 1999, c. 33). The Agreement is available on Environment Canada’s Web site at www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=969645EE-1.

The governments of Canada and Ontario released a draft COA for public comment on April 24, 2014. The 60-day public comment period ended on July 3, 2014. The Government of Canada published a response document in the Canada Gazette, Part I, on October 4, 2014.

Interested persons requiring additional information about the COA or the Great Lakes should refer to Environment Canada’s Web site at www.ec.gc.ca/grandslacs-greatlakes/ or contact Canada.Ontario.Agreement@ec.gc.ca.

February 28, 2015

LEONA AGLUKKAQ
Minister of the Environment

[9-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for living organisms (subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(1) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use, manufacture or import for a significant new activity a living organism that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(3) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use for a significant new activity a living organism that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 106(4) of the Canadian Environmental Protection Act, 1999;

Whereas a person may, pursuant to subsection 106(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 106(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and

Whereas a waiver may be granted by the Minister of the Environment under subsection 106(8) of the Canadian Environmental Protection Act, 1999 if

  • (a) in the opinion of the Ministers, the information is not needed in order to determine whether the living organism is toxic or capable of becoming toxic;
  • (b) the living organism is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the living organism so as to satisfactorily protect the environment and human health; or
  • (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;

Therefore, notice is hereby given, pursuant to subsection 106(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 106(8) of that Act.

KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch

On behalf of the Minister of the Environment

ANNEX

Waiver of Information Requirements (Subsection 106(9) of the Canadian Environmental Protection Act, 1999)

Person to whom a waiver is granted Information concerning a living organism in relation to which a waiver was granted (see note 1)
Agriculture and Agri-Food Canada Data from tests of antibiotic susceptibility (7)
OptumInsight Canada Inc. Data from tests conducted to determine the effects of the micro-organism on aquatic plant, invertebrate and vertebrate species likely to be exposed to it
Data from tests conducted to determine the effects of the micro-organism on terrestrial plant and invertebrate species likely to be exposed to it

Note 1 The number in brackets indicates the number of times that the information requirement in the second column was waived for the company between October 1, 2014, and December 31, 2014.

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals and polymers and organisms for an average of 450 notifications received.

For more information, please see the waivers Web page on the New Substances Web site at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.

[9-1-o]

DEPARTMENT OF THE ENVIRONMENT

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Waiver of information requirements for substances (subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Whereas any person who proposes to import or manufacture a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(1) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use, manufacture or import for a significant new activity a substance that is on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(3) of the Canadian Environmental Protection Act, 1999;

Whereas any person who proposes to use for a significant new activity a substance that is not on the Domestic Substances List must provide to the Minister of the Environment the information required under subsection 81(4) of the Canadian Environmental Protection Act, 1999;

Whereas a person may, pursuant to subsection 81(8) of the Canadian Environmental Protection Act, 1999, request any of the requirements to provide information under subsection 81(1), (3) or (4) of the Canadian Environmental Protection Act, 1999 to be waived; and

Whereas a waiver may be granted by the Minister of the Environment under subsection 81(8) of the Canadian Environmental Protection Act, 1999 if

  • (a) in the opinion of the Ministers, the information is not needed in order to determine whether the substance is toxic or capable of becoming toxic;
  • (b) the substance is to be used for a prescribed purpose or manufactured at a location where, in the opinion of the Ministers, the person requesting the waiver is able to contain the substance so as to satisfactorily protect the environment and human health; or
  • (c) it is not, in the opinion of the Ministers, practicable or feasible to obtain the test data necessary to generate the information;

Therefore, notice is hereby given, pursuant to subsection 81(9) of the Canadian Environmental Protection Act, 1999, that the Minister of the Environment waived the requirement to provide information in accordance with the following annex pursuant to subsection 81(8) of that Act.

KAREN L. DODDS
Assistant Deputy Minister
Science and Technology Branch

On behalf of the Minister of the Environment

ANNEX

Waiver of Information Requirements (Subsection 81(9) of the Canadian Environmental Protection Act, 1999)

Person to whom a waiver is granted Information concerning a substance in relation to which a waiver is granted (see note 2)
Allnex Canada Inc. Data in respect of a number average molecular weight
Data in respect of the maximum concentrations, expressed as a percentage, of all residual constituents having molecular weights of less than 500 daltons and of all residual constituents having molecular weights of less than 1 000 daltons
Archroma Canada Corp. Data in respect of vapour pressure (3)
Ashland Canada Corp. Data in respect of octanol/water partition coefficient
Data in respect of hydrolysis rate as a function of pH
Data in respect of water extractability
Data from an acute aquatic toxicity test
BASF Canada Inc. Data in respect of octanol/water partition coefficient
Data in respect of vapour pressure
Data from a ready biodegradability test
Brenntag Canada Inc. Data in respect of octanol/water partition coefficient
Data in respect of hydrolysis rate as a function of pH
Dorf Ketal Chemicals LLC Data in respect of melting point
Data in respect of boiling point
Data in respect of density
Data in respect of vapour pressure
Data in respect of water solubility
Data in respect of octanol/water partition coefficient
Dow Chemical Canada ULC Data in respect of octanol/water partition coefficient
E.I. DuPont Canada Inc. Data in respect of hydrolysis rate as a function of pH
Data from a skin sensitization test
Janssen Inc. Data in respect of vapour pressure
Lubrizol Canada Limited Data in respect of hydrolysis rate as a function of pH
Data from an in vivo mutagenicity test
PPG Canada Inc. Data in respect of octanol/water partition coefficient
Quadra Chemicals Ltd. Data in respect of water extractability
Data in respect of octanol/water partition coefficient
Data in respect of hydrolysis rate as a function of pH
Data from of an acute aquatic toxicity test
Shell Canada Ltd. Data in respect of hydrolysis rate as a function of pH (8)
Synoil Energy Services Data in respect of vapour pressure (2)
Tempo Canada Inc. Data in respect of vapour pressure

Note 2 The number in brackets indicates the number of times that the information requirement in the second column was waived for the company between October 1, 2014, and December 31, 2014.

EXPLANATORY NOTE

The decision to grant a waiver is made on a case-by-case basis by Environment Canada in consultation with Health Canada. On average, approximately 100 waivers are granted yearly for chemicals and polymers and organisms for an average of 450 notifications received.

For more information, please see the waivers Web page on the New Substances Web site at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=7F19FF4B-1.

[9-1-o]

DEPARTMENT OF THE ENVIRONMENT

SPECIES AT RISK ACT

Description of Ivory Gull critical habitat in the Seymour Island Bird Sanctuary

The Ivory Gull (Pagophila eburnea) is a migratory bird protected under the Migratory Birds Convention Act, 1994 and listed on Schedule 1 of the Species at Risk Act as an endangered species. In Canada, the Ivory Gull is found in Nunavut, the Northwest Territories, and Newfoundland and Labrador. It breeds exclusively in Nunavut. Ivory gulls require breeding sites that are safe from terrestrial predators. The Recovery Strategy for the Ivory Gull (Pagophila eburnea) in Canada, available at www.sararegistry.gc.ca/species/speciesDetails_e.cfm?sid=50, identifies critical habitat for the species in a number of areas, including a federally protected area.

Notice is hereby given that, pursuant to subsection 58(2) of the Species at Risk Act, subsection 58(1) of that Act applies, 90 days after this publication, to the critical habitat of the Ivory Gull, as identified in the recovery strategy for that species on the Species at Risk Public Registry, within the Seymour Island Bird Sanctuary described in the Schedule of the Migratory Bird Sanctuary Regulations made pursuant to the Migratory Birds Convention Act, 1994.

February 2, 2015

MARY TAYLOR
Director
Species at Risk Management
Canadian Wildlife Service

[9-1-o]

DEPARTMENT OF THE ENVIRONMENT

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication after screening assessment of 275 substances specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(1) of the Canadian Environmental Protection Act, 1999)

Whereas 271 of the 275 substances identified in Annex II below are substances on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the draft Screening Assessment conducted on 4 substances pursuant to paragraphs 68(b) and (c) of the Act and on the remaining 271 substances pursuant to section 74 is annexed hereby;

And whereas it is proposed to conclude that these substances do not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on the 4 substances at this time.

And notice therefore is hereby given that the ministers propose to take no further action on the remaining 271 substances at this time under section 77 of the Act.

Public comment period

Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-3231 (fax), substances@ec.gc.ca (email).

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

DAVID MORIN
Director General
Science and Risk Assessment Directorate

On behalf of the Minister of the Environment

AMANDA JANE PREECE
Director General
Safe Environments Directorate

On behalf of the Minister of Health

ANNEX I

Summary of the Draft Screening Assessment

As part of the Chemicals Management Plan, the Government of Canada is assessing and managing, where appropriate, the potential health and ecological risks associated with certain polymers under the Canadian Environmental Protection Act, 1999 (CEPA 1999). These polymers were identified as priorities for further action following the completion of categorization in 2006. A section 71 Notice for Phase 2 of the Domestic Substances List Inventory Update initiative was published in the Canada Gazette, Part I, in December 2012 to collect data on approximately 2 700 substances, including the polymers. As a result of this data collection exercise, 336 polymers were identified as not being in commerce at greater than 1 000 kg during the 2011 calendar year. A polymer rapid screening approach was applied to these 336 polymers that involved using conservative assumptions to identify polymers that warranted further evaluation of their potential to cause harm to either human health or the environment and those that were expected to have a low likelihood of causing harmful ecological or human health effects.

The ecological component of the polymer rapid screening approach consisted of four main steps to identify substances that warranted further evaluation of their potential to cause harm. The first step involved identifying the substances that have similar structural characteristics as polymeric substances that have been previously subject to risk management under the New Substances Notification Regulations (Chemicals and Polymers) [NSNR]. The second and third steps of the process involved identifying polymers that would likely have water extractability less than 2% and determining whether these polymers contained functional groups of concern described in items 1 and 5 of Schedule 7 of the NSNR, respectively. The final step involved applying different exposure scenarios using assumptions that are protective of the environment and drawing a comparison with a conservative acute ecotoxicity value for polymers.

The human health component of the polymer rapid screening approach consisted of a process to determine whether each polymer warranted further assessment from a human health perspective. A key element of the characterization of the potential risk for human health was a determination of the potential for exposure to the general population. Polymers reported to be in commerce in Canada at less than or equal to 1 000 kg during the 2011 calendar year are considered to warrant further assessment if there is evidence of direct exposure (e.g. exposure from products) of the general population in Canada. If the potential for exposure to a polymer is not expected or the polymer is likely to pose a low hazard to human health, it is concluded that the polymer is unlikely to cause harm to human health at current levels of exposure.

Proposed conclusion

In total, 61 polymers were identified as requiring further assessment (5 identified for both ecological and human health considerations, 13 identified for human health considerations only, and 43 identified for ecological considerations only). Based on the information available, it is proposed that the 275 polymers listed in Annex II do not meet any of the criteria under section 64 of CEPA 1999, since they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity, that constitute or may constitute a danger to the environment on which life depends, or that constitute or may constitute a danger in Canada to human life or health.

The draft Screening Assessment for these substances is available on the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca).

ANNEX II

Substances Identified as Not Meeting Any of the Criteria Set Out in Section 64 of the Canadian Environmental Protection Act, 1999

CAS RN (see note a) or confidential accession number (see note b) Substance name (see note c)
9003-37-6 Butanal, polymer with benzenamine
9003-50-3 Heptanal, polymer with benzenamine
9005-12-3 Poly[oxy(methylphenylsilylene)]
9008-63-3 Naphthalenesulfonic acid, sodium salt, polymer with formaldehyde
9016-83-5 Formaldehyde, polymer with methylphenol
9017-72-5 Naphthalenesulfonic acid, polymer with formaldehyde and 4,4′-sulfonylbis[phenol]
9022-96-2 1-Butanol, titanium(4+) salt, homopolymer
9060-53-1 2,5-Furandione, dihydro-3-(tetrapropenyl)-, polymer with 1-amino-2-propanol and 1,2-ethanediol
9086-40-2 Formaldehyde, polymer with (1,1,3,3-tetramethylbutyl)phenol
12624-35-0 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with 1,2-ethanediamine
24937-74-4 Formaldehyde, polymer with benzenamine and phenol
24969-10-6 Oxirane, (chloromethyl)-, polymer with oxirane
25014-31-7 Benzene, (1-methylethenyl)-, homopolymer
25035-68-1 2-Propenoic acid, 2-methyl-, polymer with ethenylbenzene and ethyl 2-propenoate
25035-90-9 2-Butenedioic acid (Z)-, dibutyl ester, polymer with ethenyl acetate
25053-96-7 Formaldehyde, polymer with 2-methylphenol
25085-17-0 1,2-Ethanediamine, N-(2-aminoethyl)-, polymer with (chloromethyl)oxirane
25155-81-1 Formaldehyde, polymer with methylbenzene
25766-18-1 Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl-, homopolymer
25951-19-3 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 5-ethenyl-2-methylpyridine and octadecyl 2-methyl-2-propenoate
26338-45-4 Aziridine, homopolymer, hydrochloride
26338-61-4 2-Furancarboxaldehyde, polymer with phenol
26591-12-8 Guanidine, cyano-, polymer with formaldehyde
26617-87-8 Oxirane, methyl-, polymer with oxirane, compd. with iodine
27553-53-3 Formaldehyde, polymer with 4-(1,1-dimethylpropyl)phenol
27754-94-5 1,2-Ethanediamine, N,N′-bis(2-aminoethyl)-, polymer with (chloromethyl)oxirane
28472-87-9 Guanidine, cyano-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine
29086-67-7 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with oxirane
30584-00-0 Formaldehyde, polymer with N-(3-aminopropyl)-1,3-propanediamine and 1,3,5-triazine-2,4,6-triamine
30705-14-7 Benzenesulfonamide, 2-methyl-, polymer with formaldehyde, 4-methylbenzenesulfonamide and 1,3,5-triazine-2,4,6-triamine
32311-19-6 Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane
32761-96-9 Benzenediazonium, 2-methoxy-4-(phenylamino)-, salt with 2,4,6-trimethylbenzenesulfonic acid (1:1) polymer with 1,1′-oxybis[4-(methoxymethyl)benzene]
32844-27-2 Carbonic dichloride, polymer with 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 4,4′-(1-methylethylidene)bis[phenol]
34323-39-2 Oxirane, (chloromethyl)-, polymer with ammonium hydroxide ((NH4)(OH))
34802-28-3 Formaldehyde, polymer with benzenamine, methyloxirane, oxirane and phenol
35297-54-2 Formaldehyde, polymer with ammonia and phenol
37189-83-6 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with N-(2-aminoethyl)-1,2-ethanediamine
37238-34-9 Formaldehyde, polymer with nonylphenol and phenol
37281-91-7 Lignin, polymer with formaldehyde and phenol
37337-65-8 Formaldehyde, polymer with phenol and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane
37604-36-7 Formaldehyde, polymer with phenol and 4-(1,1,3,3-tetramethylbutyl)phenol
37625-74-4 Urea, polymer with N-(2-aminoethyl)-1,2-ethanediamine, N,N′-bis(2-aminoethyl)-1,2-ethanediamine and formaldehyde
37625-93-7 2-Propenoic acid, polymer with (chloromethyl)oxirane and 4,4′-(1-methylethylidene)bis[phenol]
40364-42-9 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and 4,4′-methylenebis[benzenamine]
52108-93-7 (see note d) Lignin, ammonium salt
53740-05-9 Dextrin, polymer with formaldehyde
61472-52-4 Urea, polymer with N-(2-aminoethyl)-1,2-ethanediamine and formaldehyde
61827-83-6 Lignosulfonic acid, copper salt
62073-57-8 Urea, N,N′-bis(hydroxymethyl)-, polymer with formaldehyde and (hydroxymethyl)urea
63494-85-9 Formaldehyde, polymer with 4-methyl-2-nonylphenol and 4-methylphenol
63512-71-0 Formaldehyde, polymer with ammonia and chloroethane
63784-89-4 Benzenesulfonic acid, 4-amino-, monosodium salt, polymer with formaldehyde and methylphenol
63951-50-8 Naphthalenesulfonic acid, sodium salt, polymer with formaldehyde and 4,4′-sulfonylbis[phenol]
65733-73-5 Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol] and 4-(1,1-dimethylpropyl)phenol
65733-79-1 Phenol, polymer with 1-methyl-4-(1-methylethenyl)cyclohexene and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene
65733-82-6 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 4,4′-(1-methylethylidene)bis[phenol] and 4-(1,1,3,3-tetramethylbutyl)phenol
65997-11-7 Rosin, fumarated, polymer with pentaerythritol
67763-03-5 Silsesquioxanes, Me Ph
67784-93-4 Formaldehyde, polymer with 2-methylphenol and phenol, sulfonated, sodium salt
67784-97-8 Naphthalenesulfonic acids, polymers with formaldehyde and sulfonated phenol, sodium salts
67786-28-1 2-Naphthalenesulfonic acid, 6-hydroxy-, polymer with formaldehyde, 3-methylphenol and 4-methylphenol, sodium salt
67816-01-7 Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1,4-cyclohexanedimethanol, 1,3-diisocyanatomethylbenzene, hydrazine and α-hydro-ω-hydroxypoly(oxy-1,4-butanediyl)
67846-45-1 1,3-Propanediamine, N-9-octadecenyl-, (Z)-, polymer with (chloromethyl)oxirane and α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl)
67905-95-7 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4-nonylphenol
67924-33-8 Ethanol, 2,2′,2″-nitrilotris-, homopolymer, hydrochloride
67953-56-4 1,6-Hexanediamine, N-(6-aminohexyl)-, polymer with (chloromethyl)oxirane
67953-82-6 Phenol, 4-dodecyl-, polymer with 1,2-ethanediamine and formaldehyde, compd. with (dibutylamino)methanol
67970-32-5 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and methylphenol
68003-26-9 Formaldehyde, polymer with ammonia and 2-methylphenol
68015-68-9 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1-[[2-[[2-[bis(2-hydroxyethyl)amino]ethyl](2-hydroxyethyl)amino]ethyl](2-hydroxyethyl)amino]-3-(9-octadecenyloxy)-2-propanol (4:1), (Z)-
68036-98-6 Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-, polymer with formaldehyde, butylated
68037-87-6 Siloxanes and Silicones, Me vinyl
68072-45-7 1,4-Pentadien-3-one, 1,5-bis[4-(oxiranylmethoxy)phenyl]-, polymer with 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 4,4′-(1-methylethylidene)bis[phenol]
68082-23-5 Cyclosiloxanes, Me vinyl
68082-91-7 Rosin, fumarated, polymer with formaldehyde, potassium sodium salt
68082-95-1 Rosin, maleated, polymer with bisphenol A, formaldehyde, glycerol and pentaerythritol
68083-27-2 Soybean oil, polymer with ethylenediamine, linoleic acid dimer, pentaerythritol, phthalic anhydride and tall oil
68123-23-9 Nonanedioic acid, polymer with 1,2-ethanediamine, 1,6-hexanediamine and (Z,Z)-9,12-octadecadienoic acid dimer
68130-98-3 Aziridine, homopolymer, ethoxylated, phosphonomethylated
68134-00-9 Decanedioic acid, polymer with 1,2-ethanediamine, 1,6-hexanediamine and (Z,Z)-9,12-octadecadienoic acid dimer
68140-39-6 Formaldehyde, polymer with (chloromethyl)oxirane, 4,4′-(1-methylethylidene)bis[phenol], methyloxirane, methyloxirane polymer with oxirane ether with 1,2,3-propanetriol (3:1), nonylphenol and oxirane
68152-47-6 Rosin, fumarated, polymer with bisphenol A, formaldehyde and pentaerythritol
68152-60-3 Rosin, maleated, polymer with bisphenol A, formaldehyde and glycerol
68152-67-0 Rosin, maleated, polymer with tripentaerythritol
68152-68-1 Rosin, polymer with bisphenol A and formaldehyde
68154-31-4 Fatty acids, C14-18, ethoxylated propoxylated
68155-33-9 Amines, C14-18-alkyl, ethoxylated
68155-40-8 Amines, C16-18 and C18-unsatd. alkyl, ethoxylated
68188-28-3 Tall-oil rosin, maleated, polymer with pentaerythritol
68188-63-6 Rosin, maleated, polymer with bisphenol A and formaldehyde
68188-92-1 Amines, tallow alkyl, propoxylated
68201-58-1 Rosin, fumarated, polymer with formaldehyde
68213-26-3 Amines, tallow alkyl, ethoxylated propoxylated
68213-35-4 Fatty acids, C18-unsatd., dimers, polymers with ethylenediamine, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methylbenzenebutanoic acid and oleic acid
68240-07-3 Phenol, polymer with 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene
68240-08-4 Phenol, polymer with 3-methylene-6-(1-methylethyl)cyclohexene, 1-methyl-4-(1-methylethenyl)cyclohexene, 1-methyl-4-(1-methylethyl)-1,3-cyclohexadiene, 1-methyl-4-(1-methylethyl)-1,4-cyclohexadiene, 2-methyl-5-(1-methylethyl)-1,3-cyclohexadiene, 1-methyl-4-(1-methylethylidene)cyclohexene and 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene
68310-21-4 Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with α-[[(2-hydroxyethyl)[2-[[2-[(2-hydroxyethyl)octadecylamino]ethyl](2-hydroxy-2-phenylethyl)amino]ethyl]amino]methyl]benzenemethanol (2:1)
68332-89-8 Aziridine, homopolymer, propoxylated, benzyl chloride-quaternized
68333-40-4 Tung oil, polymer with boron trifluoride-phenol complex, formaldehyde, phenol, β-pinene and turpentine oil
68333-98-2 (see note e) Coconut oil, ester with polyethylene glycol mono(nonylphenyl) ether
68379-09-9 Benzenesulfonamide, ar-methyl-, polymer with formaldehyde and tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione
68390-20-5 Fatty acids, sunflower-oil, polymers with adipic acid, caprolactam, diethylenetriamine and triethylenetetramine
68400-14-6 Guanidine, cyano-, polymer with 1,2-ethanediamine sulfate (1:1) and formaldehyde
68410-22-0 (see note f) Fatty acids, C18-unsatd., dimers, reaction products with diethylenetriamine
68412-14-6 Octadecanoic acid, reaction products with 2-[(2-aminoethyl)amino]ethanol and urea
68440-73-3 Siloxanes and Silicones, di-Me, Me Ph, hydroxy-terminated
68441-69-0 1,2-Ethanediamine, polymer with 1,3-diisocyanatomethylbenzene, reaction products with oleylamine
68479-80-1 Phenol, polymer with 1,2-cyclohexanediamine, formaldehyde and 1,6-hexanediamine
68511-76-2 2,5-Furandione, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, butylated isopropylated, reaction products with triethylamine
68512-34-5 (see note g) Lignosulfonic acid, sodium salt, sulfomethylated
68513-37-1 Fatty acids, tall-oil, polymers with diethylenetriamine and linoleic acid dimers
68513-38-2 Fatty acids, tall-oil, polymers with diethylenetriamine, linoleic acid dimers and triethylenetetramine
68516-42-7 2-Propenoic acid, 2-methyl-, 2-[(1,1-dimethylethyl)amino]ethyl ester, polymer with methyl 2-methyl-2-propenoate and 2-methylpropyl 2-methyl-2-propenoate
68516-43-8 2-Propenoic acid, 2-methyl-, polymer with 2-methylaziridine, methyl 2-methyl-2-propenoate and 2-methylpropyl 2-methyl-2-propenoate
68516-87-0 Benzenesulfonic acid, 2,4-dimethyl-, polymer with formaldehyde and 4,4′-sulfonylbis[phenol], ammonium sodium salt
68527-87-7 Formaldehyde, polymer with 2-ethoxyethanol and phenol
68540-48-7 9,12-Octadecadienoic acid (Z,Z)-, dimer, compd. with N,N′-bis(2-aminoethyl)-1,2-ethanediamine
68540-71-6 Benzoic acid, 2-hydroxy-, polymer with formaldehyde, 2-methylphenol and nonylphenol
68541-21-9 9,12-Octadecadienoic acid (Z,Z)-, polymer with (chloromethyl)oxirane and 4,4′-(1-methylethylidene)bis[phenol]
68541-77-5 Decanedioic acid, polymer with 2-aminoethanol, 1,2-ethanediamine and (Z,Z)-9,12-octadecadienoic acid dimer
68552-99-8 Fatty acids, vegetable-oil, polymers with phthalic anhydride and rosin
68553-78-6 Oils, oiticica, polymers with boron trifluoride-phenol complex, formaldehyde, phenol, β-pinene and turpentine oil
68554-18-7 Rosin, fumarated, polymer with glycerol, ammonium salt
68604-06-8 Castor oil, hydrogenated, polymer with ethylenediamine, 12-hydroxyoctadecanoic acid and sebacic acid
68605-92-5 Fatty acids, tall-oil, reaction products with polyethylenepolyamines, compds. with polyethylene glycol decyl ether phosphate
68606-78-0 Naphthenic acids, esters with polytriethanolamine
68609-24-5 Formaldehyde, polymer with benzenamine, propoxylated
68610-07-1 Formaldehyde, polymers with isobutylenated phenol
68610-55-9 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and phenyloxirane, reaction products with 4,4′-methylenebis[benzenamine]
68610-75-3 2-Propenoic acid, 2-methyl-, methyl ester, polymer with 2-mercaptoethanol, reaction products with ammonia and N,N′,2-tris(6-isocyanatohexyl)imidodicarbonic diamide
68650-48-6 Fatty acids, C18-unsatd., dimers, polymers with C18-unsatd. alkyl amine dimers and ethylenediamine
68890-97-1 Aziridine, homopolymer, compd. with (chloromethyl)benzene
68891-01-0 Benzenesulfonamide, ar-methyl-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, butylated
68910-67-8 Rosin, fumarated maleated, polymer with formaldehyde, potassium sodium salt
68915-81-1 Linseed oil, polymer with bisphenol A, bisphenol A diglycidyl ether, diethylenetriamine, formaldehyde, glycidyl Ph ether and pentaethylenehexamine
68920-24-1 Fatty acids, dehydrated castor-oil, polymers with bisphenol A, epichlorohydrin, fumaric acid and rosin
68920-41-2 Fatty acids, tall-oil, reaction products with polyethylenepolyamines, compds. with polyethylene glycol monooctyl ether phosphate
68937-31-5 4,6,10-Dodecatrien-3-one, 7,11-dimethyl-, cyclized, by-products from, fractionation residues
68951-99-5 Siloxanes and Silicones, di-Me, Me vinyl, mono(vinyl group)-terminated
68952-00-1 Siloxanes and Silicones, di-Me, mono(vinyl group)-terminated
68953-74-2 Aziridine, homopolymer, ethoxylated, phosphonomethylated, sodium salt
68956-65-0 Naphthenic acids, polymers with ethylenimine, compds. with linoleic acid dimer
68988-41-0 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, reaction products with diethanolamine and polyethylene glycol monooleate
68988-81-8 Hexanedioic acid, polymer with bis(2-chloroethyl) (1-hydroxyethyl)phosphonate, 2-chloroethyl hydrogen (2-chloroethyl)phosphonate, 2-chloroethyl hydrogen (1-hydroxyethyl)phosphonate, (E)-2,3-dibromo-2-butene-1,4-diol, 1,3-diisocyanatomethylbenzene and 2,2′-oxybis[ethanol], reaction products with diethanolamine, hydrochlorides
68988-82-9 Hexanedioic acid, polymer with bis(2-chloroethyl) (1-hydroxyethyl)phosphonate, 2-chloroethyl hydrogen (2-chloroethyl)phosphonate, 2-chloroethyl hydrogen (1-hydroxyethyl)phosphonate, (E)-2,3-dibromo-2-butene-1,4-diol, 1,3-diisocyanatomethylbenzene and 1,2-propanediol, reaction products with diethanolamine, hydrochlorides
68989-80-0 Fatty acids, linseed-oil, polymers with glycerol, maleic anhydride, phthalic anhydride, rosin and tung oil
69011-21-8 Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, sulfonated, ammonium salts
69178-40-1 Formaldehyde, polymer with benzenamine and 2-ethylbenzenamine
69898-35-7 Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane, butylated
69898-36-8 Urea, polymer with formaldehyde and 1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane, butylated ethylated
69929-35-7 Decanedioic acid, polymer with 1,2-ethanediamine, (Z,Z)-9,12-octadecadienoic acid dimer and 4,4′-(1,3-propanediyl)bis[piperidine]
69929-44-8 9,12-Octadecadienoic acid (Z,Z)-, dimer, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine and 1,2-ethanediamine, acetate
70528-79-9 Sulfite liquors and Cooking liquors, spent, polymer with formaldehyde
70693-20-8 Cyanamide, reaction products with carbon dioxide, ethylene oxide and 1-octadecanamine
70750-07-1 Formaldehyde, polymer with N-(2-aminoethyl)-1,2-ethanediamine, benzylated
70851-21-7 Siloxanes and Silicones, di-Me, (C3-33-alkyloxy)-terminated
71042-85-8 2-Propenoic acid, 2-methyl-, telomer with 2-[(1,1-dimethylethyl)amino]ethyl 2-methyl-2-propenoate, 1-dodecanethiol, methyl 2-methyl-2-propenoate and exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl 2-methyl-2-propenoate
71077-22-0 Benzoic acid, 2-hydroxy-, polymer with formaldehyde, 4-nonylphenol and zinc oxide (ZnO)
71412-29-8 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, telomer with tert-dodecanethiol, ethenylbenzene, isodecyl 2-methyl-2-propenoate and 2-propenoic acid, compd. with 2-(dimethylamino)ethanol
72121-75-6 Formaldehyde, polymer with 2,2′-iminobis[ethanol], 4,4′-(1-methylethylidene)bis[phenol], nonylphenol and 1,3,5-triazine-2,4,6-triamine
72207-55-7 Benzenamine, ethylenated, distn. residues
72361-56-9 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, (butoxymethyl)oxirane and (chloromethyl)oxirane
72828-15-0 Benzene, diethenyl-, polymer with ethenylbenzene, sulfonated, ammonium salts
72968-37-7 Amines, C12-18-alkyl, ethoxylated
73049-34-0 Alcohols, C16-20, ethoxylated propoxylated
73297-33-3 Poly(oxy-1,2-ethanediyl), α-[tris[1-(methylphenyl)ethyl]phenyl]-ω-hydroxy-
75790-74-8 1,2,3-Propanetriol, polymer with 1,3-diisocyanatomethylbenzene, hydrazine, methyloxirane and oxirane
76649-36-0 Formic acid, compd. with N-(2-aminoethyl)-1,2-ethanediamine polymer with formaldehyde and urea
76649-37-1 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, ammonia, (chloromethyl)oxirane, formaldehyde and formic acid, formate hydrochloride sulfate
76649-45-1 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, formaldehyde and formic acid
76649-46-2 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, formaldehyde and formic acid, formate hydrochloride sulfate
76822-95-2 Imides, cyclic, from C15-20 α-alkene-maleic anhydride copolymer and (Z)-N-9-octadecenyl-1,3-propanediamine
79770-99-3 Fatty acids, C18-unsatd., dimers, distn. lights, reaction products with α,α′-(1-methyl-1,3-propanediyl)bis[ω-hydroxypoly(oxy-1,2-ethanediyl)]
82640-14-0 Naphthalenesulfonic acids, polymers with formaldehyde, sulfonated 1,1′-oxybis[methylbenzene] and sulfonylbis[phenol], ammonium sodium salts
89394-61-6 Formaldehyde, polymer with N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine and benzenamine
95012-79-6 Tetraglycerol, monododecyl ether
95649-04-0 Naphthalenesulfonic acids, polymers with formaldehyde, sulfonated 1,1′-biphenyl and sulfonylbis[phenol], ammonium sodium salts
95649-08-4 Formaldehyde, polymers with sulfonated terphenyl and sulfonylbis[phenol], ammonium sodium salts
96591-18-3 Fatty acids, tall-oil, reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol and formaldehyde, polymers with acrylonitrile, Et acrylate and Me methacrylate
96591-23-0 Formaldehyde, polymers with sulfonated 1,1′-biphenyl, sulfonated terphenyl and sulfonylbis[phenol], ammonium sodium salts
97969-64-7 Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1-aziridineethanol, formaldehyde, 1,6-hexanediol and 1,3,5-triazine-2,4,6-triamine
98654-27-4 Fatty acids, dehydrated castor-oil, polymers with dehydrated castor oil, 2-(dimethylamino)ethanol, isononanoic acid, isophthalic acid, linseed oil, maleic anhydride and pentaerythritol
100588-10-1 2-Propenoic acid, polymer with 2,2′-[1,2-ethanediylbis(oxymethylene)]bis[oxirane] and sodium 2-propenoate
102082-95-1 2-Propenoic acid, ammonium salt, polymer with 2-propenamide and 2-propenenitrile
102561-59-1 Hexanedioic acid, polymer with N-(2-aminoethyl)-1,3-propanediamine and N,N″-1,2-ethanediylbis[1,3-propanediamine]
102984-13-4 2-Propenoic acid, sodium salt, polymer with 2,2′-[1,2-ethanediylbis(oxymethylene)]bis[oxirane]
103458-43-1 2-Propenoic acid, polymer with 2-(diethylamino)ethyl 2-propenoate and 2-propenamide, sulfate
104376-66-1 Formaldehyde, polymers with branched nonylphenol, ethylene oxide and hexamethylenediamine
106214-62-4 Fatty acids, soya, polymers with adipic acid, 1,6-hexanediol, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, isophthalic acid and trimethylolpropane, compds. with triethylamine
106214-63-5 Fatty acids, soya, polymers with benzoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, isophthalic acid, pentaerythritol and phthalic anhydride, compds. with triethylamine
108563-09-3 Amines, tallow alkyl, ethoxylated, 4-dodecylbenzenesulfonates (salts)
110392-46-6 Formaldehyde, reaction products with 1,4-benzenediol and m-phenylenediamine, sulfurized
110720-55-3 Oxirane, methyl-, polymer with oxirane, ether with [[3-[(2-hydroxymethylethyl)amino]propyl]imino]bis[propanol] (3:1), N-tallow alkyl derivs., sulfates (esters), ammonium salts
112484-41-0 Formaldehyde, polymer with 4-(1,1,3,3-tetramethylbutyl)phenol, hydrobromic acid-terminated
115559-71-2 Sulfurous acid, monosodium salt, reaction products with m-cresol-formaldehyde-nonylphenol polymer
115559-72-3 Sulfurous acid, monosodium salt, reaction products with m-cresol-formaldehyde polymer
116265-69-1 Formaldehyde, reaction products with hexamethylenediamine and oxidized ethylene-propene polymer
117985-54-3 Benzenesulfonic acid, hydroxy-, monosodium salt, polymer with benzenamine, formaldehyde, 1,3,5-triazine-2,4,6-triamine and urea, bisulfited
118460-96-1 Formaldehyde, polymer with methylphenol, nonylphenol and phenol, bisulfited
118685-17-9 Benzenesulfonic acid, 4-amino-, polymer with formaldehyde, 2-methylphenol and phenol, bisulfited
119147-80-7 Octadecanoic acid, 12-hydroxy-, homopolymer, 2-hydroxy-3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl ester, polymer with methyl 2-methyl-2-propenoate and oxiranylmethyl 2-methyl-2-propenoate, 2-methyl-2-propenoate 4-nitrobenzoate
121028-89-5 2-Propenoic acid, 2-methyl-, telomer with butyl 2-methyl-2-propenoate, 1-dodecanethiol, 2-mercaptoethanol, methyl 2-methyl-2-propenoate and 2-(3-oxazolidinyl)ethyl 2-methyl-2-propenoate
121053-40-5 Amines, N-coco alkyltrimethylenedi-, compds. with acrylic acid-N-(butoxymethyl)-2-propenamide-Et acrylate-styrene polymer and 2-(dimethylamino)ethanol
121053-44-9 Pentanedioic acid, dimethyl ester, polymer with N-(2-aminoethyl)-1,2-ethanediamine, ammonia and (chloromethyl)oxirane
121053-47-2 Propanoic acid, 2-hydroxy-, compd. with (chloromethyl)oxirane polymer with 2-(methylamino)ethanol, 4,4′-(1-methylethylidene)bis[phenol] and α,α′-[(1-methylethylidene)di-4,1- phenylene]bis[ω-hydroxypoly(oxy-1,2-ethanediyl)]
121372-53-0 2-Propenoic acid, 2-methyl-, methyl ester, telomer with butyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, 2-(methylamino)ethanol and oxiranylmethyl 2-methyl-2-propenoate, (±)-2-hydroxypropanoate (salt) (S)-2-hydroxypropanoate (salt)
121375-94-8 Urea, polymer with benzenamine, formaldehyde and 1,3,5-triazine-2,4,6-triamine, bisulfited
121617-09-2 Alcohols, C16-18, propoxylated
121617-10-5 Rosin, polymd., polymer with maleic anhydride, phthalic anhydride, tall oil, tetrahydroabietyl alc. and trimethylolpropane
122966-99-8 Phenol, 2,4,6-tris(1-methylpropyl)-, reaction products with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane], ethoxylated
123774-67-4 Formaldehyde, polymer with ammonium hydroxide ((NH4)(OH)), 4-(1,1-dimethylethyl)phenol and phenol
124578-08-1 1,3-Butadiene, 2-chloro-, homopolymer, reaction products with zinc oxide
125249-27-6 Formaldehyde, polymer with methanol and nonylphenol
125302-07-0 2-Propenamide, polymer with formaldehyde and morpholine
125302-08-1 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol], 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and 4-nonylphenol
125328-35-0 Amides, from hydrogenated tallow and tetraethylenepentamine, polymers with epichlorohydrin and polyethylene glycol, acetates (salts)
125328-72-5 2-Propenoic acid, 2-methyl-, methyl ester, telomer with butyl 2-propenoate, tert-dodecanediol, ethenylbenzene, 2-(methylamino)ethanol, oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol
125329-08-0 9-Octadecenoic acid (Z)-, polymer with copper(2+) sulfate (1:1), 2,5-furandione and oxybis[propanol]
125351-98-6 Aziridine, homopolymer, reaction products with epichlorohydrin and polyethylene glycol, acetates
125352-08-1 Amines, N-C12-22-alkyltrimethylenedi-, ethoxylated
125352-10-5 Sulfuric acid copper(2+) salt (1:1), polymer with 2,5-furandione and oxybis[propanol]
125378-97-4 2-Propenoic acid, butyl ester, polymer with ethenylbenzene, methyl 2-methyl-2-propenoate, oxiranylmethyl 2-methyl-2-propenoate, 1,2-propanediol mono(2-methyl-2-propenoate) and 2,2′-thiobis[ethanol]
125826-31-5 1,2-Benzenedicarboxylic acid, di-2-propenyl ester, polymer with (Z)-butyl hydrogen 2-butenedioate, butyl 2-methyl-2-propenoate, ethenylbenzene, 2-ethylhexyl 2-propenoate, 2-hydroxyethyl 2-methyl-2-propenoate, 12-hydroxyoctadecanoic acid homopolymer 2-hydroxy-3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl ester, methyl 2-methyl-2-propenoate, 2-methyl-2-propenoic acid and oxiranylmethyl 2-methyl-2-propenoate, 4-nitrobenzoate
125826-39-3 Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1,4-cyclohexanedimethanol, 1,3-diisocyanatomethylbenzene, hydrazine and α-hydro-ω-hydroxypoly(oxy-1,4-butanediyl), compd. with N,N-diethylethanamine
128801-08-1 Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol], 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)bis[oxirane] and phenol
128971-25-5 Fatty acids, polymers with isophthalic acid, linoleic acid dimer and triethylenetetramine
129126-83-6 Linseed oil, polymer with benzoic acid, formaldehyde, pentaerythritol, phenol, phthalic anhydride, rosin, TDI, 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione and trimethylolpropane
129126-87-0 Linseed oil, polymer with benzoic acid, formaldehyde, pentaerythritol, phenol, phthalic anhydride, rosin, TDI, 3a,4,7,7a-tetrahydro-1,3-isobenzofurandione and trimethylolpropane, compds. with 2-(dimethylamino)ethanol
129420-90-2 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane]
129783-27-3 Guanidine, cyano-, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, sulfonated, sodium salts
129783-43-3 Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-iminobis[ethanol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane], reaction products with polyethylene glycol monostearate
129783-50-2 Benzenesulfonamide, 4-amino-, polymer with (chloromethyl)oxirane, 4,4′-(1-methylethylidene)bis[2,6-dibromophenol] and 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane]
129870-85-5 Hexanedioic acid, polymer with 1,3-isobenzofurandione, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and oxybis[propanol], 2-hydroxyethyl acrylate-blocked
144030-98-8 Benzenesulfonic acid, 4-hydroxy-, polymer with formaldehyde and urea, reaction products with aniline, 1,3-bis(hydroxymethyl)urea, 4,5-dihydroxy-1,3-bis(hydroxymethyl)-2-imidazolidinone, disodium disulfite, formaldehyde, tetrahydro-3,5-bis(hydroxymethyl)-1
144031-00-5 Propanoic acid, 2-hydroxy-, compds. with bisphenol A-epichlorohydrin-polyethylene glycol ether with bisphenol A (2:1) polymer-2-(methylamino)ethanol reaction products
144238-33-5 2-Propenoic acid, 2-methyl-, reaction products with bisphenol A-bisphenol A diglycidyl ether polymer benzoate and styrene
147170-42-1 2-Propenoic acid, telomer with 1-dodecanethiol, S-oxides, ammonium salts
150226-40-7 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 4,4′-(1-methylethylidene)bis[phenol] and 4-methylphenol, magnesium oxide complex
150226-41-8 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4,4′-(1-methylethylidene)bis[phenol], magnesium oxide complex
154862-02-9 Rosin, polymd., polymer with maleic anhydride, phthalic anhydride, tall oil, tetrahydroabietyl alc. and trimethylolethane
155240-18-9 Benzenesulfonic acid, dodecyl-, reaction products with succinic anhydride monopolyisobutylene derivs., tetraethylenepentamine and zinc oxide
160611-46-1 2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, C8-rich C7-9-isoalkyl esters
165307-61-9 1,3-Isobenzofurandione, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 1,2,3-propanetriol, benzoate (9Z,12Z)-9,12-octadecadienoate
176227-30-8 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and oxirane, esters with tall-oil fatty acids
10008-0 (see note h) Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and diethanolamine and poly(oxyalkylenediyl), α-(1-oxo-9-octadecenyl)-ω-hydroxy-, (Z)-
10009-1 (see note i) Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis[oxirane] and bis(2-substituted ethyl) amine
10011-3 (see note j) Cyanoguanidine polymer with diammonium sulfate and an alkyl aldehyde
10017-0 (see note k) Amido amine composed of 1,3-propanediamine, N-(3-aminoalkyl)-N-methyl and fatty acids, C18-unsaturated dimers
10697-5 (see note l) Metal alkenylsuccinate
10709-8 (see note m) Piperazine, 1,2-alkyldiamine, formaldehyde and (chloromethyl)oxirane, polymer
11048-5 (see note n) Fatty acids, tall-oil, reaction products with polyethylene glycol, and dicarboxylic acid, salt with reaction products of fatty acids, tall-oil and polyalkylenepolyamine
11054-2 (see note o) Nonyl phenol, ethoxylated, monoester with dicarboxylic acid, neutralized with reaction products of tall-oil fatty acids and polyalkylenepolyamine
11065-4 (see note p) Fatty acids, tall oil, reaction product with polyalkyenepolyamine and phosphoric acid
11108-2 (see note q) Phosphoric acid, polysubstituted amino resin, amino substituted borate
11111-5 (see note r) Amino amide composed of 1,4-piperazinedialkylamine and fatty acids, C18-unsatd. dimers
11114-8 (see note s) Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane] and diethanolamine and poly(oxyalkylenediyl), α.-oxooctadecyl)-ω-hydrox-
11118-3 (see note t) Phenol, 4,4′-(1-methylethylidene)bis-, polymer with chloromethyl)oxirane, 1,3,5-triazine-2,4,6-triamine polymer with formaldehyde, and substituted benzoic acid, 1-propanol, 2-(dimethylamino)-2-methyl-, salt
11126-2 (see note u) Substituted bis disubstituted heteropolycycle, polymer with (chloromethyl)oxirane, dihydro-2,5-furandione and 4,4′-(1-methylethylidene) bis[phenol], alkanoate, 2-propenoate, metal salt
11135-2 (see note v) Tall oil rosin, polymer with alkanoic acid, disubstituted heteropolycyclic acid and 1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-
11147-5 (see note w) Polymer of aromatic acids, tall oil fatty acid, polyols, N,N-dimethylethanolamine, methanol, melamine and formaldehyde
11154-3 (see note x) Polymer of linseed oil, pentaerythritol, isophthalic acid, monobasic acid, rosin, and maleic anhydride
11176-7 (see note y) Fatty acids, C18-unsaturated, dimers, polymers with tall-oil fatty acids and tetraethylenepentamine, reaction products with bisphenol A-epichlorhydrin condensate and polyalkylenepolyamines
11201-5 (see note z) Polymer of linseed and chinawood oils and synthetic rosin, pentaerythritol and solid resin
11431-1 (see note aa) Poly(allyl methacrylate/butyl acrylate/2-substituted ethyl acrylate/methacrylic acid/methyl methacrylate) 2-amino-2-methyl-1-propanol salt
11436-6 (see note bb) Reaction product of alkenylsarcosine, polyoxypropylenediamine and zinc stearate
11459-2 (see note cc) Naphtha (petroleum), light steam cracked, debenzenised, polymer with alkylphenol and formaldehyde
11461-4 (see note dd) Rosin, maleated, polymer with a carbonyl compound and pentaerythritol, calcium, magnesium and zinc salts
11470-4 (see note ee) Rosin, polymer with p-tert-butylphenol, formaldehyde, glycerol and an alkylphenol
11471-5 (see note ff) Rosin, polymer with an alkylphenol, bisphenol A, formaldehyde and glycerol
11472-6 (see note gg) Rosin, maleated, polymer with a carbonyl compound, calcium, magnesium and zinc salts
11475-0 (see note hh) Fatty acids, polymerized, reaction products with diethylenetriamine and tall-oil fatty acids
11512-1 (see note ii) Phenol, 4,4′-(methylethylidene)bis-, polymer with (chloromethyl)oxirane, methyloxirane, and combined [oxy(methyl-1,2-ethanediyl)]
11513-2 (see note jj) Reaction product of alkylphenol, formaldehyde, monoethanolamine, ethylene oxide and propylene oxide
11588-5 (see note kk) Reaction product of: (4,4′-(1-Methylethylidene)bisphenol polymer with substituted methyl(oxirane) and 5-amino-1,3,3 trimethyl cyclohexane methanamine and N,N-bis(aminoethyl)-1,2-ethanediamine
11589-6 (see note ll) Reaction product of: 4,4′-(1-Methyethylidene)bisphenol polymer with substituted methyl(oxirane) and 5-amino-1,3,3-trimethyl cyclohexane methanamine and 2,2,4 (or 2,4,4)trimethyl-1,6-hexanediamine
  • Note a The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.
  • Note b A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note c Masked names are allowed by CEPA 1999 if the publication of the explicit chemical or biological name of a substance would result in the release of confidential business information.
  • Note d These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note e These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note f These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note g These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note h A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note i A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note j A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note k A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note l A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note m A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note n A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note o A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note p A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note q A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note r A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note s A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note t A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note u A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note v A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note w A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note x A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note y A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note z A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note aa A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note bb A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note cc A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note dd A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note ee A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note ff A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note gg A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note hh A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note ii A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note jj A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note kk A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).
  • Note ll A confidential accession number is given to a substance whose identity is confidential and chemical name masked pursuant to sections 3 to 7 of the Masked Name Regulations (Canada 1994).

[9-1-o]

DEPARTMENT OF THE ENVIRONMENT

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication after screening assessment of 612 substances specified on the Domestic Substances List (paragraphs 68(b) and (c) or subsection 77(1) of the Canadian Environmental Protection Act, 1999)

Whereas the 576 of the 612 substances identified in Annex II below are substances on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the draft Screening Assessment conducted under paragraphs 68(b) and (c) of the Act on 36 substances, and under section 74 for the remaining 576 substances, is annexed hereby;

And whereas it is proposed to conclude that the 612 substances do not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on 36 of the substances at this time.

Notice is further given that the ministers propose to take no further action on the remaining 576 substances at this time under section 77 of the Act.

Public comment period

Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Environment Canada, Gatineau, Quebec K1A 0H3, 819-938-3231 (fax), substances@ec.gc.ca (email).

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

DAVID MORIN
Director General
Science and Risk Assessment Directorate

On behalf of the Minister of the Environment

AMANDA JANE PREECE
Director General
Safe Environments Directorate

On behalf of the Minister of Health

ANNEX I

Summary of the Draft Screening Assessment

As part of the Government of Canada’s Chemicals Management Plan, a section 71 notice for the second phase of the Domestic Substances List (DSL) Inventory Update (IU) initiative was published in the Canada Gazette, Part I, on December 1, 2012, to collect data on approximately 2 700 substances. As a result, 869 substances were identified as candidates for rapid screening. The substances included in this report were candidates for rapid screening because they were identified as being in commerce across Canada at a total of 1 000 kg/year or less, according to information submitted pursuant to section 71 of the Canadian Environmental Protection Act, 1999 (CEPA 1999) regarding commercial activity in Canada under Phase 2 of the DSL IU.

The majority of the 869 substances met the categorization criteria for persistence or bioaccumulation and inherent toxicity to human or non-human organisms or for “greatest potential for exposure” to humans under subsection 73(1) of CEPA 1999. Some substances considered in this assessment had been identified as posing a high hazard to human health based on classifications by other national or international agencies for carcinogenicity, genotoxicity, developmental toxicity or reproductive toxicity.

A rapid screening approach was applied that involved using conservative assumptions to identify substances that warrant further evaluation of their potential to cause harm to either human health or the environment, and those that are expected to have a low likelihood of causing harmful ecological or human health effects.

The ecological component consisted of two main steps to identify substances that warrant further evaluation of their potential to cause harm. The first step involved applying different exposure scenarios using assumptions that are protective of the environment. The second step involved a mechanical process to identify whether or not a substance appeared on any of a wide range of lists or in sources of information relating to ecological hazard or exposure. This step flagged substances that have been identified by domestic or international initiatives as possibly being of greater concern due to their ecological hazard properties or elevated potential for environmental release.

The human health component consisted of a process to determine whether the substance warranted further assessment based on the potential for exposure to the general population. Substances reported to be in commerce in Canada at less than or equal to 1 000 kg/year are considered to warrant further assessment only if there is evidence of direct exposure (e.g. exposure from products or processed foods) for the general population in Canada. If the potential for exposure is considered to be negligible for a substance, it is concluded that the substance is unlikely to cause harm to human health at current levels of exposure.

In total, 257 substances were identified as requiring further assessment (40 identified for both ecological and human health considerations, 199 identified for human health considerations only, and 18 identified for ecological considerations only). For the remaining 612 substances, this rapid screening approach indicated that current use patterns and quantities in commerce are unlikely to result in concerns for organisms or the broader integrity of the environment, or for human health in Canada.

Proposed conclusion

It is proposed to conclude that these 612 substances do not meet any of the criteria set out in section 64 of CEPA 1999.

Because these 612 substances are listed on the Domestic Substances List, their import and manufacture in Canada are not subject to notification under the New Substances Notification Regulations of CEPA 1999. Although a risk to the environment or human health has not been identified, 39 substances in this assessment are recognized as having properties of concern. There may be a concern for the environment or for human health if exposures to these substances were to increase. Options on how best to monitor changes in the use profiles of these substances are being investigated and may include application of the Significant New Activity provisions and/or addition to the DSL IU.

The draft Screening Assessment for these substances is available on the Government of Canada’s Chemical Substances Web site (www.chemicalsubstances.gc.ca).

ANNEX II

Substances identified as not meeting any of the criteria set out in section 64 of the Canadian Environmental Protection Act, 1999

CAS RN (see note 3) Domestic Substances List name
50-41-9 Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
50-50-0 Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-benzoate
50-52-2 10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-
50-53-3 10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-
51-28-5 Phenol, 2,4-dinitro-
51-48-9 L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-
52-86-8 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1- (4-fluorophenyl)-
57-12-5 Cyanide
60-87-7 10H-Phenothiazine-10-ethanamine, N,N,α-trimethyl-
60-99-1 10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,β-trimethyl-, (βR)-
70-30-4 Phenol, 2,2′-methylenebis[3,4,6-trichloro-
72-33-3 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17α)-
72-69-5 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-
79-54-9 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,9,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,4bα,10aα)]-
80-10-4 Silane, dichlorodiphenyl-
83-66-9 Benzene, 1-(1,1-dimethylethyl)-2-methoxy-4-methyl-3,5-dinitro-
84-96-8 10H-Phenothiazine-10-propanamine, N,N,β-trimethyl-
85-00-7 Dipyrido[1,2-a:2′,1′-c]pyrazinediium, 6,7-dihydro-, dibromide
88-58-4 1,4-Benzenediol, 2,5-bis(1,1-dimethylethyl)-
89-47-4 Butanoic acid, 3-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)-
91-50-9 Benzoic acid, 2-[[2-methyl-3-[4-(1-methylethyl)phenyl]propylidene]amino]-, methyl ester
95-19-2 1H-Imidazole-1-ethanol, 2-heptadecyl-4,5-dihydro-
95-73-8 (see note 1a) Benzene, 2,4-dichloro-1-methyl-
97-23-4 Phenol, 2,2′-methylenebis[4-chloro-
98-95-3 Benzene, nitro-
99-82-1 Cyclohexane, 1-methyl-4-(1-methylethyl)-
100-46-9 (see note 1b) Benzenemethanamine
100-99-2 Aluminum, tris(2-methylpropyl)-
101-65-5 Carbamic acid, (methylenedi-4,1-phenylene)bis-, diphenyl ester
105-58-8 (see note 1c) Carbonic acid, diethyl ester
109-72-8 Lithium, butyl-
111-83-1 Octane, 1-bromo-
112-29-8 Decane, 1-bromo-
112-52-7 Dodecane, 1-chloro-
115-71-9 2-Penten-1-ol, 5-(2,3-dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methyl-, stereoisomer
118-65-0 Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R-(1R,4Z,9S)]-
120-83-2 Phenol, 2,4-dichloro-
121-21-1 Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, 2-methyl-4-oxo-3-(2,4-pentadienyl)-2-cyclopenten-1-yl ester, [1R-[1α[S(Z)],3β]]-
123-69-3 Oxacycloheptadec-8-en-2-one, (Z)-
128-66-5 Dibenzo[b,def]chrysene-7,14-dione
129-09-9 Anthra[2,1-d:6,5-d′]bisthiazole-6,12-dione, 2,8-diphenyl-
129-73-7 Benzenamine, 4,4′-(phenylmethylene)bis[N,N-dimethyl-
133-66-4 (see note 1d) Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt
135-88-6 (see note 1e) 2-Naphthalenamine, N-phenyl-
140-29-4 (see note 1f) Benzeneacetonitrile
140-41-0 (see note 1g) Acetic acid, trichloro-, compd. with N′-(4-chlorophenyl)-N,N-dimethylurea (1:1)
140-73-8 1,6-Hexanediamine, N,N′-bis(3-phenyl-2-propenylidene)-
141-38-8 (see note 1h) Oxiraneoctanoic acid, 3-octyl-, 2-ethylhexyl ester
149-11-1 Hexanoic acid, 2-ethyl-, copper(2+) salt
151-50-8 Potassium cyanide (K(CN))
297-76-7 19-Norpregn-4-en-20-yne-3,17-diol, diacetate, (3β,17α)-
302-79-4 Retinoic acid
357-57-3 Strychnidin-10-one, 2,3-dimethoxy-
360-70-3 Estr-4-en-3-one, 17-[(1-oxodecyl)oxy]-, (17β)-
420-04-2 Cyanamide
485-19-8 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-, (1S)-
506-64-9 Silver cyanide (Ag(CN))
506-68-3 Cyanogen bromide ((CN)Br)
514-10-3 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,4bα,10aα)]-
519-73-3 Benzene, 1,1′,1″-methylidynetris-
522-00-9 10H-Phenothiazine-10-ethanamine, N,N-diethyl-α-methyl-
537-00-8 Acetic acid, cerium(3+) salt
537-01-9 Carbonic acid, cerium(3+) salt (3:2)
541-09-3 Uranium, bis(acetato-O)dioxo-
542-76-7 Propanenitrile, 3-chloro-
542-83-6 Cadmium cyanide (Cd(CN)2)
544-19-4 Formic acid, copper(2+) salt
544-92-3 Copper cyanide (Cu(CN))
556-61-6 Methane, isothiocyanato-
560-88-3 Benzoic acid, 2-hydroxy-, 1,7,7-trimethylbicyclo[2.2.1]hept-2-yl ester, endo-
563-63-3 Acetic acid, silver(1+) salt
587-26-8 Carbonic acid, lanthanum(3+) salt (3:2)
590-28-3 Cyanic acid, potassium salt
592-01-8 Calcium cyanide (Ca(CN)2)
592-82-5 Butane, 1-isothiocyanato-
592-85-8 Thiocyanic acid, mercury(2+) salt
605-01-6 Benzene, pentaethyl-
622-20-8 Benzene, 1,1′-[1,2-ethanediylbis(thio)]bis-
739-71-9 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,β-trimethyl-
751-94-0 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, monosodium salt, (3α,4α,8α,9β,11α,13α, 14β,16β,17Z)-
814-91-5 Ethanedioic acid, copper(2+) salt (1:1)
917-70-4 Acetic acid, lanthanum(3+) salt
950-33-4 Cyclododecane, 1,1-dimethoxy-
969-33-5 Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride
979-32-8 Estra-1,3,5(10)-triene-3,17-diol (17β)-, 17-pentanoate
1025-15-6 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tri-2-propenyl-
1096-48-6 9,10-Anthracenedione, 1-(cyclohexylamino)-
1120-44-1 9-Octadecenoic acid (Z)-, copper(2+) salt
1135-66-6 2H-2,4a-Methanonaphthalene, 1,3,4,5,6,7-hexahydro-1,1,5,5-tetramethyl-, (2S)-
1172-18-5 2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
1209-61-6 5-Oxatricyclo[8.2.0.04,6]dodecane, 4,9,12,12-tetramethyl-
1299-86-1 Aluminum carbide (Al4C3)
1313-97-9 Neodymium oxide (Nd2O3)
1314-20-1 Thorium oxide (ThO2)
1314-61-0 Tantalum oxide (Ta2O5)
1324-58-9 Diindolo[3,2-b:3′,2′-m]triphenodioxazinetrisulfonic acid, 8,18-dichloro-5,15-diethyl-5,15-dihydro-, trisodium salt
1329-99-3 Cyclohexane, 1-methyl-4-(1-methylethyl)-, tetradehydro deriv.
1331-61-9 Benzenesulfonic acid, dodecyl-, ammonium salt
1332-14-5 Sulfuric acid, copper(2+) salt, basic
1332-65-6 Copper chloride hydroxide (Cu2Cl(OH)3)
1344-67-8 Copper chloride
1405-92-1 1H-3a,7-Methanoazulene-6-methanol, 2,3,4,7,8,8a-hexahydro-3,8,8-trimethyl-, acetate, [3R-(3α,3aβ,7β,8aα)]-
1446-61-3 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, [1R-(1α,4aβ,10aα)]-
1470-61-7 Silver, (diethylcarbamodithioato-S,S′)-
1478-61-1 Phenol, 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis-
1622-61-3 1-Pyrrolidinepropanol, α-cyclohexyl-α-phenyl-, hydrochloride
1746-23-2 Benzene, 1-(1,1-dimethylethyl)-4-ethenyl-
1796-92-5 Benzoic acid, 5-[(3-carboxy-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidene)(2,6-dichlorophenyl)methyl]-2-hydroxy-3-methyl-, disodium salt
1799-84-4 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester
1817-68-1 Phenol, 4-methyl-2,6-bis(1-phenylethyl)-
1922-67-4 1H-Naphtho[2,3-c]pyran, 3,4,6,7,8,9-hexahydro-4,6,6,9,9-pentamethyl-
2026-24-6 1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, acetate, [1R-(1α,4aβ,10aα)]-
2144-53-8 2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester
2162-73-4 Benzene, 2,4-diisocyanate-1,3,5-tris(1-methylethyl)-
2386-52-9 Methanesulfonic acid, silver(1+) salt
2451-84-5 Hexanedioic acid, bis(phenylmethyl) ester
2611-00-9 3-Cyclohexene-1-carboxylic acid, 3-cyclohexen-1-ylmethyl ester
2944-30-1 9,10-Anthracenedione, 1,4-bis[(4-methoxyphenyl)amino]-
2966-50-9 Acetic acid, trifluoro-, silver(1+) salt
3042-75-9 Benzeneacetic acid, α-chloro-α-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride
3089-55-2 Hexanedioic acid, octyl phenylmethyl ester
3251-84-1 Methanaminium, N-[4-[[4-(cyclohexylamino)-1-naphthalenyl][4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, chloride
3253-39-2 2-Propenoic acid, 2-methyl-, (1-methylethylidene)di-4,1-phenylene ester
3315-16-0 Cyanic acid, silver(1+) salt
3333-62-8 2H-1-Benzopyran-2-one, 7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-
3444-14-2 Carbonic acid, copper(1+) salt
3526-75-8 5-Azulenemethanol, decahydro-α,α,3,8-tetramethyl-, [3S-(3α,3aβ,5α,8α,8aβ)]-
3564-75-8 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,β-trimethyl-, (-)-
3572-52-9 (see note 1i) 1,1′-Biphenyl -3-carboxylic acid, 2-hydroxy-, 2-(diethylamino)ethyl ester
3688-79-7 7H-Benz[de]anthracen-7-one, 3-methoxy-
3860-63-7 9,10-Anthracenedione, 1,5-dihydroxy-4,8-bis(methylamino)-
3910-35-8 1H-Indene, 2,3-dihydro-1,1,3-trimethyl-3-phenyl-
4091-99-0 Benzoic acid, 2-[3,6-bis(acetyloxy)-2,7-dichloro-9H-xanthen-9-yl]-
4105-12-8 Cyclohexanol, 3-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)-, [1α,2α(1S,3S),4α,6α]-
4111-54-0 2-Propanamine, N-(1-methylethyl)-, lithium salt
4196-86-5 1,3-Propanediol, 2,2-bis[(benzoyloxy)methyl]-, dibenzoate
4203-77-4 [3,3′-Bianthra[1,9-cd]pyrazole]-6,6′(1H,1′H)-dione, 1,1′-diethyl-
4216-01-7 7H-Benzo[e]perimidine-4-carboxamide, N-(9,10-dihydro-9,10-dioxo-1-anthracenyl)-7-oxo-
4270-70-6 Sulfonium, triphenyl-, chloride
4330-99-8 10H-Phenothiazine-10-propanamine, N,N,β-trimethyl-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
4424-87-7 Benzo[1,2-c:4,5-c′]diacridine-6,9,15,18(5H,14H)-tetrone
4499-91-6 Docosanoic acid, lithium salt
4702-65-2 9,10-Anthracenedione, 4,8-diamino-1,5-dihydroxy-2-(4-hydroxy-3-methylphenyl)-
4759-48-2 Retinoic acid, 13-cis-
4802-20-4 Cyclohexaneethanethiol, 3-mercapto-β,4-dimethyl-
5284-79-7 Cyclohexanone, 2,6-bis[(4-azidophenyl)methylene]-4-methyl-
5875-45-6 Phenol, 2,5-bis(1,1-dimethylethyl)-
6028-47-3 2-Pentanol, 4-methyl-, hydrogen phosphorodithioate
6070-16-2 Hexanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)-
6130-43-4 Heptanoic acid, tridecafluoro-, ammonium salt
6144-04-3 Benzene, (1-methylethenyl)-, dimer
6196-94-7 Benzene, 1-ethyl-4-(1-phenylethyl)-
6196-95-8 Benzene, 1,2-dimethyl-4-(1-phenylethyl)-
6221-92-7 Cyclododecanol, acetate
6252-76-2 Xanthylium, 9-(2-carboxyphenyl)-3-[(2-methylphenyl)amino]-6-[(2-methyl-4-sulfophenyl)amino]-, hydroxide, inner salt, monosodium salt
6291-95-8 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(2-methyl-2-propenyl)-
6408-57-7 Benzenesulfonic acid, 2,2′-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-butyl-, disodium salt
6661-40-1 Benzenesulfonic acid, 2-ethoxy-5-[[4-[[4-[(4-ethoxy-3-sulfophenyl)amino]phenyl](1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]amino]-, monosodium salt
6804-07-5 (see note 1j) Hydrazinecarboxylic acid, [(1,4-dioxido-2-quinoxalinyl)methylene]-, methyl ester
6990-06-3 29-Nordammara-17(20),24-dien-21-oic acid, 16-(acetyloxy)-3,11-dihydroxy-, (3α,4α,8α,9β,11α,13α,14β,16β,17Z)-
7098-08-0 9,10-Anthracenedione, 4,8-diamino-1,5-dihydroxy-2-(4-hydroxyphenyl)-
7158-25-0 4,9:5,8-Dimethano-1H-benz[f]indene, 3a,4,4a,5,8,8a,9,9a-octahydro-
7360-44-3 Aluminum, (acetato-O)dihydroxy-
7435-02-1 Octanoic acid, cerium salt
7439-15-8 Benzene, 1-ethyl-4-(2-phenylethyl)-
7439-91-0 Lanthanum
7439-94-3 Lutetium
7440-45-1 Cerium
7440-65-5 Yttrium
7488-49-5 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)-
7647-10-1 Palladium chloride (PdCl2)
7717-62-6 Benzeneacetic acid, 1-phenyl-1,2-ethanediyl ester
7758-88-5 Cerium fluoride (CeF3)
7774-29-0 Mercury iodide (HgI2)
7782-39-0 Deuterium
7783-33-7 Mercurate(2-), tetraiodo-, dipotassium, (T-4)-
7783-49-5 Zinc fluoride (ZnF2)
7783-70-2 Antimony fluoride (SbF5)
7783-86-0 Iron iodide (FeI2)
7783-96-2 Silver iodide (AgI)
7784-09-0 Phosphoric acid, trisilver(1+) salt
7789-45-9 Copper bromide (CuBr2)
7790-80-9 Cadmium iodide (CdI2)
7790-86-5 Cerium chloride (CeCl3)
7790-98-9 Perchloric acid, ammonium salt
7803-58-9 Sulfamide
7803-63-6 Sulfuric acid, monoammonium salt
8023-64-1 (see note 1k) Balsams, Peru, white
8038-93-5 Sodium aluminum chlorhydroxy lactate
9008-34-8 Resin acids and Rosin acids, manganese salts
10024-42-7 Aluminum sodium sulfate
10024-93-8 Neodymium chloride (NdCl3)
10025-67-9 Sulfur chloride (S2Cl2)
10025-74-8 Dysprosium chloride (DyCl3)
10028-17-8 Tritium
10042-88-3 Terbium chloride (TbCl3)
10045-89-3 Sulfuric acid, ammonium iron(2+) salt (2:2:1)
10049-07-7 Rhodium chloride (RhCl3)
10049-23-7 Telluric acid (H2TeO3)
10099-59-9 Nitric acid, lanthanum(3+) salt
10102-05-3 Nitric acid, palladium(2+) salt
10108-73-3 Nitric acid, cerium(3+) salt
10138-04-2 Sulfuric acid, ammonium iron(3+) salt (2:1:1)
10138-41-7 Erbium chloride (ErCl3)
10138-52-0 Gadolinium chloride (GdCl3)
10168-81-7 Nitric acid, gadolinium(3+) salt
10361-65-6 Phosphoric acid, triammonium salt
10361-79-2 Praseodymium chloride (PrCl3)
10361-82-7 Samarium chloride (SmCl3)
10361-92-9 Yttrium chloride (YCl3)
10361-93-0 Nitric acid, yttrium(3+) salt
10402-16-1 9-Octadecenoic acid (Z)-, copper salt
10402-33-2 Benzeneacetic acid, 2-methoxy-4-(2-propenyl)phenyl ester
10484-56-7 Naphthalene, 2-butoxy-
10579-93-8 Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1S-(1R,4E,9S)]-
10580-02-6 Titanate(2-), bis[ethanedioato(2-)-O,O′]oxo-, diammonium, (SP-5-21)-
11028-42-5 Cedrene
12003-63-3 Aluminate (AlO21-), potassium
12004-40-9 Aluminate (AlO33-), strontium (2:3)
12013-15-9 Copper hydroxide sulfate (Cu3(OH)4(SO4))
12014-14-1 Cadmium titanium oxide (CdTiO3)
12027-06-4 Ammonium iodide ((NH4)I)
12027-67-7 Molybdate (Mo7O246-), hexaammonium
12030-97-6 Titanate (TiO32-), dipotassium
12034-34-3 Titanate (TiO32-), disodium
12049-50-2 Titanate (TiO32-), calcium (1:1)
12057-24-8 Lithium oxide (Li2O)
12061-16-4 Erbium oxide (Er2O3)
12075-68-2 Aluminum, trichlorotriethyldi-
12124-99-1 Ammonium sulfide ((NH4)(SH))
12135-77-2 Ammonium sulfide ((NH4)2(S5))
12138-09-9 Tungsten sulfide (WS2)
12192-57-3 Gold, [1-(thio-.kappa.S)-D-glucopyranosato-.kappa.O2
12196-21-3 Hemimorphite (Zn4(OH)2O(SiO3)2.H2O)
12227-77-9 Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, chloride, aluminum salt
12254-24-9 Aluminate (Al12O192-), strontium (1:1)
12307-90-3 Rhodium, chloro[(1,2,5,6-η)-1,3,5,7-cyclooctatetraene](pyridine)-
12542-85-7 Aluminum, trichlorotrimethyldi-
12593-60-1 Ammonium phosphate sulfate ((NH4)2H3(PO4)(SO4))
12794-95-5 (see note 1l) Silicic acid, ammonium salt
13005-35-1 D-Gluconic acid, copper salt
13011-54-6 Phosphoric acid, monoammonium monosodium salt
13019-04-0 Cyclohexanone, 2,4-bis(1,1-dimethylethyl)-
13106-76-8 Molybdate (MoO42-), diammonium, (T-4)-
13393-93-6 1-Phenanthrenemethanol, tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-
13444-93-4 Osmium chloride (OsCl3)
13446-48-5 Nitrous acid, ammonium salt
13453-07-1 Gold chloride (AuCl3)
13453-87-7 Sulfurous acid, dilithium salt
13454-72-3 Metaphosphoric acid (HPO3), cerium(3+) salt
13465-98-0 Sulfurous acid, disilver(1+) salt
13573-16-5 Chromate(1-), diamminetetrakis(thiocyanato-N)-, ammonium, (OC-6-11)-
13596-12-8 Aluminum fluoride oxide (AlFO)
13598-65-7 Rhenate (ReO41-), ammonium, (T-4)-
13693-11-3 Sulfuric acid, titanium(4+) salt (2:1)
13709-38-1 Lanthanum fluoride (LaF3)
13709-49-4 Yttrium fluoride (YF3)
13786-79-3 13-Oxabicyclo[10.1.0]trideca-4,8-diene, 1,5,9-trimethyl-
13820-53-6 Palladate(2-), tetrachloro-, disodium, (SP-4-1)-
13821-15-3 Aluminate(1-), tetrafluoro-, sodium, (T-4)-
13823-29-5 Nitric acid, thorium(4+) salt
14049-51-5 Aluminum, hydroxybis(octanoato-O)-
14220-17-8 Nickelate(2-), tetrakis(cyano-C)-, dipotassium, (SP-4-1)-
14263-73-1 Cuprate(3-), tetrakis(cyano-C)-, tripotassium, (T-4)-
14284-93-6 Ruthenium, tris(2,4-pentanedionato-O,O′)-, (OC-6-11)-
14307-35-8 Chromic acid (H2CrO4), dilithium salt
14475-17-3 Carbonic acid, praseodymium salt
14816-18-3 3,5-Dioxa-6-aza-4-phosphaoct-6-ene-8-nitrile, 4-ethoxy-7-phenyl-, 4-sulfide
15007-61-1 Aluminum potassium sulfate
15114-15-5 9,10-Anthracenedione, 4,8-diamino-2-(4-ethoxyphenyl)-1,5-dihydroxy-
15281-91-1 Cuprate(3-), tetrakis(cyano-C)-, trisodium, (T-4)-
15336-18-2 Rhodate(3-), hexachloro-, triammonium, (OC-6-11)-
15467-06-8 9-Octadecenoic acid, 12-hydroxy-, monolithium salt, [R-(Z)]-
15680-42-9 Copper, [1-[[(2-hydroxyphenyl)imino]methyl]-2-naphthalenolato(2-)-N,O,O′]-
15710-63-1 Aluminum ammonium sulfate
15752-05-3 Iridate(3-), hexachloro-, triammonium, (OC-6-11)-
16774-21-3 Cerate(2-), hexakis(nitrato-O)-, diammonium, (OC-6-11)-
16871-54-8 Platinate(2-), hexachloro-, (OC-6-11)-
16903-35-8 Aurate(1-), tetrachloro-, hydrogen, (SP-4-1)-
16919-19-0 Silicate(2-), hexafluoro-, diammonium
16919-31-6 Zirconate(2-), hexafluoro-, diammonium, (OC-6-11)-
16919-58-7 Platinate(2-), hexachloro-, diammonium, (OC-6-11)-
16921-30-5 Platinate(2-), hexachloro-, dipotassium, (OC-6-11)-
16923-58-3 Platinate(2-), hexachloro-, disodium, (OC-6-11)-
16940-92-4 Iridate(2-), hexachloro-, diammonium, (OC-6-11)-
16941-12-1 Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-
17202-41-4 1-Nonanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-nonadecafluoro-, ammonium salt
17439-11-1 Titanate(2-), hexafluoro-, dihydrogen, (OC-6-11)-
17527-29-6 2-Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester
17831-71-9 2-Propenoic acid, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester
17836-88-3 Aluminate(1-), diethyldihydro-, sodium, (T-4)-
18263-25-7 Hexadecanoic acid, 2-bromo-
18400-34-5 Bismuth carbonate
18908-70-8 Benzene, 1-ethyl-2-(1-phenylethyl)-
18908-71-9 Benzene, 1-ethyl-3-(1-phenylethyl)-
19014-53-0 9,10-Anthracenedione, 1-amino-2-[4-[(hexahydro-2-oxo-1H-azepin-1-yl)methyl]phenoxy]-4-hydroxy-
19125-99-6 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-butyl-6-(butylamino)-
19398-61-9 (see note 1m) Benzene, 1,4-dichloro-2-methyl-
19941-28-7 1-Phenanthrenecarboxylic acid, tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester, [1R-(1α,4aß,4bα ,7ß,8aß,10aα)]-
21064-19-7 1,5,9-Cyclododecatriene, 1,5,9-trimethyl-
21656-02-0 Rhodium hydroxide (Rh(OH)3)
22722-98-1 Aluminate(1-), dihydrobis(2-methoxyethanolato-O,O′)-, sodium
23149-52-2 Thiosulfuric acid (H2S2O3), disilver(1+) salt
24304-00-5 Aluminum nitride (AlN)
24447-78-7 2-Propenoic acid, (1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl)ester
24484-01-3 Copper, chloro[tris(2-chloroethyl) phosphite-P]-
24593-34-8 Hexanoic acid, 2-ethyl-, cerium salt
24772-51-8 Aluminum, bis(2-butanolato)(ethyl 3-oxobutanoato-O1′,O3)-, (T-4)-
25155-18-4 Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[methyl-4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride
25339-17-7 Isodecanol
25567-55-9 Phenol, tetrachloro-, sodium salt
25614-03-3 Ergotaman-3′,6′,18-trione, 2-bromo-12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α)-
26401-27-4 Phosphorous acid, isooctyl diphenyl ester
26545-58-4 (see note 1n) Naphthalenesulfonic acid, methylenebis-, disodium salt
26603-40-7 (see note 1o) 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris(3-isocyanatomethylphenyl)-
26628-22-8 Sodium azide (Na(N3))
26747-90-0 1,3-Diazetidine-2,4-dione, 1,3-bis(3-isocyanatomethylphenyl)-
27080-90-6 Disulfide, bis(dimethylphenyl)
27157-94-4 Phosphorodithioic acid, O,O-bis(methylphenyl) ester
27441-86-7 Imidodisulfuric acid, ammonium salt
28984-89-6 1,1′-Biphenyl, phenoxy-
29935-35-1 Arsenate(1-), hexafluoro-, lithium
31113-23-2 Aurate(1-), tetrachloro-, ammonium, (SP-4-1)-
31288-44-5 9,10-Anthracenedione, 1,5-diamino-4,8-dihydroxy(4-methoxyphenyl)-
31529-83-6 9,10-Anthracenedione, 1,5-diamino-4,8-dihydroxy(4-hydroxyphenyl)-
31884-77-2 (see note 1p) Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-, hydrochloride, hydrate (1:2:1)
32222-06-3 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1α,3β,5Z,7E)-
32510-27-3 2(3H)-Benzothiazolethione, copper salt
33703-04-7 Acetic acid, 2,2′,2″-[(1,1,3-tributyl-1-distannathianyl-3-ylidene)tris(thio)]tris-, triisooctyl ester
33704-59-5 1H-Indene, 2,3,4,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-
33704-60-8 1H-Indene, octahydro-1,1,2,3,3-pentamethyl-
34455-03-3 1-Hexanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)-
35164-39-7 Propanoic acid, 2-methyl-, ester with 2,2,4-trimethyl-1,3-pentanediol monobenzoate
35171-52-9 Arsenic triiodide
38303-23-0 Cyclododecoxazole, 4,5,6,7,8,9,10,11,12,13-decahydro-
38462-23-6 Pyridine, 4-(4,8-dimethyl-3,7-nonadienyl)-
38970-76-2 Benzoic acid, 2-hydroxy-, dilithium salt
40785-62-4 Cyclododeca[c]furan, 1,3,3a,4,5,6,7,8,9,10,11,13a-dodecahydro-
41284-31-5 1,4-Benzenedicarboxylic acid, 2-[[4-(2,2-dicyanoethenyl)-3-methylphenyl]ethylamino]ethyl methyl ester
42757-85-7 1H-Benz[f]indene-1,3(2H)-dione, 2-(3-hydroxy-2-quinolinyl)-
47107-74-4 Copper, iodo(triphenylphosphine)-
47742-71-2 Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]-
50288-23-8 Arsenic triiodide
50471-44-8 2,4-Oxazolidinedione, 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-
50542-90-0 2H-1-Benzopyran-2-one, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-4-methyl-
52236-80-3 Acetic acid, [4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]phenoxy]-, ethyl ester
52475-89-5 3-Cyclohexene-1-carboxaldehyde, 3-(4-methyl-3-pentenyl)-
52591-27-2 2-Propenoic acid, 3,3,4,4,5,5,6,6,6-nonafluorohexyl ester
53004-93-6 Butanoic acid, 2-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester
53422-16-5 Octadecanoic acid, 12-hydroxy-, methyl ester, lithium salt
54464-54-9 Ethanone, 1-[1,6-dimethyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]-
55200-89-0 Copper hydroxide sulfate
56208-99-2 Aluminum, bis(2-ethylhexanoato-O)(2-propanolato)-
56211-60-0 Potassium titanium fluoride
57499-57-7 Ethanone, 1-[1,6-dimethyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]-
58102-02-6 3-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-
58394-64-2 Hexanedioic acid, 2-ethylhexyl phenylmethyl ester
58478-76-5 Octadecanoic acid, 12-hydroxy-, calcium lithium salt
60270-55-5 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, potassium salt
60304-36-1 Aluminum potassium fluoride
60364-28-5 Pentanoic acid, 2-propyl-, bismuth salt
61617-09-2 9H-Dibenzo[b,d]pyran-9-one, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl -, (6aR,10aR)-
61788-56-5 Naphthenic acids, lithium salts
61788-80-5 Resin acids and Rosin acids, iron salts
61788-83-8 (see note 1q) Oils, herring, sulfated, sodium salts
61789-75-1 Quaternary ammonium compounds, benzyldimethyltallow alkyl, chlorides
61790-11-2 Fatty acids, tall-oil, zinc salts
61790-20-3 Naphthenic acids, rare earth salts
61790-54-3 Naphthenic acids, compds. with N-tallow alkyltrimethylenediamines
62563-80-8 Vetiverol, acetate
62625-30-3 Phenol, 4,4′-(3H-2,1-benzoxathiol-3-ylidene)bis[2-bromo-6-methyl-, S,S-dioxide, monosodium salt
62638-04-4 Cyclohexanebutanoic acid, silver(1+) salt
63148-76-5 Benzoxazolium, 3-ethyl-5-phenyl-2-[2-[[3-(3-sulfopropyl)-2(3H)-benzoxazolylidene]methyl]-1-butenyl]-, hydroxide, inner salt
63568-35-4 Naphthalenedisulfonic acid, diisononyl-, compd. with 1,1′-iminobis[2-propanol] (1:2)
64129-94-8 Pentanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, [1R-(1α,2β,5α)]-
64754-89-8 (see note 1r) Naphthenic acids (petroleum), crude
64755-02-8 Fatty acids, tallow, lithium salts
65816-20-8 Benzoic acid, 4-[[(ethylphenylamino)methylene]amino]-, ethyl ester
66071-82-7 Fatty acids, tallow, hydrogenated, lithium salts
67567-23-1 Butanoic acid, 3,3-bis[(1,1-dimethylpropyl)dioxy]-, ethyl ester
67584-53-6 Glycine, N-ethyl-N-[(tridecafluorohexyl)sulfonyl]-, potassium salt
67584-58-1 1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, iodide
67584-62-7 Glycine, N-ethyl-N-[(pentadecafluoroheptyl)sulfonyl]-, potassium salt
67634-12-2 Benzoic acid, 2-[[[4-(4-hydroxy-4-methylpentyl)-3-cyclohexenyl]methylene]amino]-, methyl ester
67801-30-3 4-Penten-3-one, 5-(2,4,6-trimethyl-3-cyclohexen-1-yl)-
67801-31-4 3-Buten-2-one, 3-methyl-4-(3,5,6-trimethyl-3-cyclohexen-1-yl)-
67801-32-5 4-Penten-3-one, 5-(3,5,6-trimethyl-3-cyclohexen-1-yl)-
67801-36-9 1H-Indole-1-heptanol, η-1H-indol-1-yl-α,α,ε-trimethyl
67801-37-0 1H-Indole, 1,1-(2-phenylethylidene)bis-
67801-47-2 Benzoic acid, 2-[(3,7-dimethyl-2,6-octadienylidene)amino]-, methyl ester
67845-42-5 Benzoic acid, 2-[(3,7-dimethyl-6-octenylidene)amino]-, methyl ester
67893-02-1 1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester
67905-40-2 Oxiranecarboxylic acid, 3-methyl-3-[2-(2,6,6-trimethyl-2-cyclohexen-1-yl)ethenyl]-, methyl ester
67924-13-4 Benzoic acid, 2-[[2-(phenylmethylene)octylidene]amino]-, methyl ester
67939-98-4 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[2-(phosphonooxy)ethyl]-, diammonium salt
67940-02-7 1-Heptanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, monohydrochloride
68039-12-3 1H-Imidazolium, 1-ethyl-4,5-dihydro-3-(2-hydroxyethyl)-2-(8-heptadecenyl)-, ethyl sulfate
68083-40-9 Methanone, [2-hydroxy-4-[2-hydroxy-3-(octyloxy)propoxy]phenyl]phenyl-
68092-49-9 Methanone, [4-[3-(decyloxy)-2-hydroxypropoxy]-2-hydroxyphenyl]phenyl-
68131-32-8 (see note 1s) Sulfite liquors and Cooking liquors, spent, fermented
68139-87-7 Fatty acids, tall-oil, compds. with diethylenetriamine-naphthenic acid reaction products
68155-64-6 1-Propanone, 1-[6-methyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]-
68155-65-7 1-Propanone, 1-[6-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl]-
68186-32-3 1,2,4-Benzenetricarboxylic acid, isooctyl ester
68186-99-2 C.I. Pigment Red 231
68187-06-4 Naphthalenesulfonic acid, di-C5-6-alkyl derivs., compds. with butylamine
68187-41-7 Phosphorodithioic acid, O,O-di-C1-14-alkyl esters
68187-59-7 (see note 1t) Coal, anthracite, calcined
68201-19-4 Barium, acetate tallow fatty acids complexes
68228-09-1 Benzoic acid, 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methyl]amino]-, ethyl ester
68259-07-4 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, ammonium salt
68259-14-3 1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-methyl-
68259-15-4 1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-methyl-
68298-13-5 1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-methyl-
68307-87-9 (see note 1u) Calcium, acetate hydrogenated tallow fatty acids complexes
68308-19-0 Fatty acids, C6-19-branched, copper(2+) salts
68309-34-2 Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-nortall-oil alkyl, chlorides
68333-32-4 Phenol, mixed di-Me and mono-Me derivs., isobutenylated, distn. residues
68334-11-2 Fatty acids, tall oil, compds. with 2-[(2-hydroxyphenyl)methylene]hydrazinecarboximidamide
68400-01-1 Formic acid, compd. with 2-[2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]ethoxy]-N,N-dimethyl-1-propanamine (1:1)
68412-02-2 2,5-Furandione, dihydro-, mono-C11-13-alkenyl derivs.
68412-83-9 Sulfuric acid, mono-C8-30-alkyl esters, compds. with triethanolamine
68442-12-6 9-Octadecenoic acid (Z)-, 2-mercaptoethyl ester, reaction products with dichlorodimethylstannane, sodium sulfide(Na2S) and trichloromethylstannane
68478-78-4 9-Octadecenoic acid (Z)-, reaction products with 2-amino-2-methyl-1-propanol
68478-92-2 Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes
68514-63-6 Naphthenic acids, cerium(4+) salts
68515-67-3 Copper, 2-ethylhexanoate naphthenate 3,5,5-trimethylhexanoate complexes
68515-89-9 Barium, carbonate nonylphenol complexes
68515-93-5 Phenol, nonyl derivs., sulfides
68527-78-6 Benzoic acid, 2-[[2-(phenylmethylene)heptylidene]amino]-, methyl ester
68527-79-7 7-Octen-2-ol, 8-(1H-indol-1-yl)-2,6-dimethyl
68551-38-2 Balsams, copaiba, sulfurized, silver salts
68551-39-3 Balsams, Douglas-fir, mixed with turpentine oil, titanium salts
68555-62-4 2-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-
68555-72-6 1-Pentanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(2-hydroxyethyl)-
68555-73-7 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)-
68555-75-9 1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)-N-methyl-
68555-76-0 1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)-N-methyl-
68555-81-7 1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, chloride
68585-32-0 Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
68603-64-5 Amines, N-(hydrogenated tallow alkyl)trimethylenedi-
68608-33-3 Terpenes and Terpenoids, cedarwood-oil, hydroxy, acetates
68609-03-0 Copper, C6-19-branched carboxylate naphthenate complexes
68610-24-2 (see note 1v) C.I. Pigment Yellow 157
68611-23-4 3-Pentanone, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, reaction products with 2-propyn-1-ol
68647-36-9 Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, tungstatesilicate
68647-67-6 Sesquiterpenes and Sesquiterpenoids, guaiac wood-oil
68648-44-2 Pyrethrins and Pyrethroids, manufg.-residues
68683-18-1 Neodecanoic acid, silver(1+) salt
68738-99-8 Benzoic acid, 2-[[[2,4(or 3,5)-dimethyl-3-cyclohexen-1-yl]methylene]amino]-, methyl ester
68784-83-8 Yttrium oxide sulfide (Y2O2S), europium-doped
68845-33-0 Cyclohexane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethyl)-, didehydro deriv.
68859-25-6 C.I. Pigment Yellow 37
68901-22-4 Cyclohexanone, 4-[(3,3-dimethylbicyclo[2.2.1]hept-2-yl)methyl]-2-methyl-
68908-88-3 Benzene, ethyl-, benzylated
68909-13-7 Bastnaesite, calcined conc.
68916-14-3 (see note 1w) Oils, amyris, acetylated
68916-31-4 Balsams, Douglas-fir, sulfurized, ruthenium salts
68916-32-5 Balsams, mixed copaiba and Douglas-fir, sulfurized, silver salts
68918-07-0 Sulfonic acids, petrolatum, sodium salts
68920-10-5 (see note 1x) Fats, animal, mixed with vegetable oils, deodorizer distillates
68922-09-8 Cyclohexanol, 2-methoxy-4-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-
68928-29-0 1-Octadecanaminium, N,N-diethyl-N-methyl-, (OC-6-11)-hexakis(cyano-C)ferrate(4-) (4:1)
68938-42-1 Paraffin waxes and Hydrocarbon waxes, chloro, reaction products with naphthalene
68952-33-0 Tar acids, cresylic, C8-rich, phosphates
68952-90-9 1-Propanaminium, N,N-bis(2-aminoethyl)-2-hydroxy-N-methyl-, N,N-ditallow acyl derivs., Me sulfates (salts)
68954-59-6 9-Octadecenoic acid (Z)-, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfate
68955-54-4 Amines, C16-22-tert-alkyl
68956-12-7 (see note 1y) Fatty acids, C18-unsatd., dimers, distn. lights
68957-60-8 1-Pentanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, monohydrochloride
68957-61-9 1-Hexanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, monohydrochloride
68957-62-0 1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-
68990-00-1 Resin acids and Rosin acids, decarboxylated, potassium salts
68990-27-2 Balsams, copaiba, sulfurized, mixed with turpentine, gold salts
68990-92-1 Tallow, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfate
69011-12-7 1,2-Benzenedicarboxylic acid, 3,4,5,6-tetrachloro-, butyl ester
69012-57-3 Flue dust, cadmium-refining
69012-60-8 Flue dust, lead-tin alloy-manufg.
69012-63-1 Flue dust, zinc-refining
69012-86-8 Ashes (residues), zinc-refining
69029-45-4 Lead, dross, antimony-rich
69029-51-2 Lead, antimonial, dross
69029-60-3 Zinc, desilverizing skims
69029-61-4 Bismuth, refinery lead chloride residues
69029-63-6 Calcines, cadmium residue
69029-74-9 Calcines, lead ore conc.
69029-79-4 Residues, lead smelting
69029-83-0 Residues, zinc smelting
69029-91-0 Slimes and Sludges, cadmium sump tank
70024-67-8 Benzenesulfonic acid, C16-24-alkyl derivs.
70225-15-9 1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, compd. with 2,2-iminobis[ethanol] (1:1)
70225-16-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with 2,2-iminobis[ethanol] (1:1)
70892-62-5 1-Naphthalenepropanol, α-ethenyldecahydro-2-hydroxy-α,2,5,5,8a-pentamethyl-, [1R-[1α(R),2β,4aβ,8aα]]-, oxidized
70914-18-0 Tallow, hydrogenated, reaction products with 2-[(2-aminoethyl)amino]ethanol, compds. with di-Et sulfates
71205-27-1 9,10-Anthracenedione, 1,8-diamino-4,5-dihydroxy-, brominated
71487-01-9 Quaternary ammonium compounds, dicoco alkyldimethyl, nitrites
71827-03-7 Avermectin A1a, 5-O-demethyl-22,23-dihydro-
71889-01-5 (see note 1z) Silane, chlorotrimethyl-, hydrolysis products with silica
72230-85-4 Terpenes and Terpenoids, copaiba-oil, hydroxy, acetates
72403-67-9 3-Cyclohexene-1-methanol, 3(or 4)-(4-methyl-3-pentenyl)-, acetate
72749-59-8 Quaternary ammonium compounds, tri-C6-12-alkylmethyl, chlorides
72927-96-9 2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-9,10-dioxo-4-[(2,4,6-trimethylphenyl)amino]-, monolithium salt
73018-55-0 Platinum, dicarbonyldichloro-, reaction products with 2,4,6-triethenyl-2,4,6-trimethylcyclotrisiloxane
73049-75-9 (see note 1aa) Quaternary ammonium compounds, benzyldi-C12-18-alkylmethyl, chlorides
73240-13-8 Benzoic acid, 2-hydroxy-, 1-methyl-1,3-propanediyl ester
73309-46-3 Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[(4-ethoxyphenyl)amino]-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, chloride
73570-52-2 Phenoxazin-5-ium, 3,7-bis(diethylamino)-, nitrate
75701-31-4 Xanthylium, 9-(2,5-dicarboxyphenyl)-3,6-bis(diethylamino)-, hydroxide, inner salt
79665-42-2 Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, copper(1+) (OC-6-11)-hexakis(cyano-C)ferrate(4-) (2:2:1)
79864-11-2 Benzenamine, N,N-methanetetraylbis[4-[(4-isocyanatophenyl)methyl]-
80301-64-0 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-
82537-67-5 1,3,8-Triazaspiro[4.5]decane-2,4-dione, 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-
83950-19-0 Benzenamine, 4-[(2-chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-2-methyl-, sulfate (2:1)
83968-92-7 Ethanaminium, N-[4-[(2-chlorophenyl)(1-methyl-2-phenyl-1H-indol-3-yl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, acetate
84434-47-9 Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(methylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate
84776-83-0 (see note 1bb) Resin acids and Rosin acids, esters with trimethylolpropane
85005-73-8 Phenoxazin-5-ium, 3-(ethylamino)-2-methyl-7-[(2-methylphenyl)amino]-, chloride
85187-74-2 Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis[5-[[4-(methylamino)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, sodium salt
85338-07-4 Aluminum, chloro hydroxy sulfo-1,2-benzenedicarboxylate complexes
85585-93-9 Carbonic acid, aluminum magnesium salt, basic
85586-48-7 Urea, N,N″-(methylenedi-4,1-phenylene)bis[N-[3-(triethoxysilyl)propyl]-
85736-59-0 Naphthenic acids, bismuth salts
87396-22-3 (see note 1cc) Phosphonic acid, [[(phosphonomethyl)imino]bis[6,1-hexanediylnitrilobis(methylene)]]tetrakis-, reaction products with ammonia-diethylene glycol reaction product morpholine derivs. residues
90066-13-0 Xanthylium, 9-(2,4-dicarboxyphenyl)-3,6-bis(diethylamino)-, hydroxide, inner salt
90623-14-6 Amides, from C18-24 fatty acids, N,N-dimethyl-1,3-propanediamine and hydrogenated tallow fatty acids, compds. with di-Me sulfate
90989-74-5 (see note 1dd) Blood, meal
91053-53-1 Limestone, reaction product with bauxite and gypsum
91744-55-7 (see note 1ee) Glycerides, lard mono-, hydrogenated
93334-05-5 Fatty acids, montan-wax, sodium salts
93892-03-6 Butanoic acid, 2-methyl-5-(1-methylethenyl)cyclohexyl ester, (1α,2β,5α)-
93892-05-8 Butanoic acid, 3-methyl-, 2-methyl-5-(1-methylethenyl)cyclohexyl ester, (1α,2β,5α)-
93919-04-1 Butanoic acid, 2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-yl ester
93940-59-1 Octanoic acid, 5-methyl-2-(1-methylethyl)cyclohexyl ester, (1α,2β,5α)-
94094-93-6 (see note 1ff) Benzene, mono-C10-C13-alkyl derivs., fractionation bottoms, heavy ends
94248-34-7 Benzoic acid, 2-[[(trimethyl-3-cyclohexen-1-yl)methylene]amino]-, methyl ester
94279-42-2 Ferrate(4-), hexakis(cyano-C)-, oxidized N,N-dimethylbenzenamine-N-ethyl-2-methylbenzenamine-formaldehyde reaction products copper(1+) salts
94386-39-7 Butanoic acid, 3-methyl-, 2-methyl-5-(1-methylethenyl)-2-cyclohexen-1-yl ester
94386-40-0 Butanoic acid, 3-methyl-, [4-(1-methylethenyl)-1-cyclohexen-1-yl]methyl ester
97375-25-2 Platinum, carbonyl chloro 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane complexes
97862-60-7 Fatty acids, C20-28, compds. with 2-(methylamino)ethanol
100085-57-2 Oils, fish, hydrogenated, reaction products with N,N-dimethyl-1,3-propanediamine, di-Me sulfate-quaternized
103443-41-0 Xanthylium, 3,6-bis(diethylamino)-9-[2-(methoxycarbonyl)phenyl]-, molybdatetungstatephosphate
104037-85-6 Benzoic acid, 2-[[3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl]amino]-, methyl ester
106068-87-5 Benzothiazolium, 5-chloro-2-[[5-[(5-chloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)ethylidene]-3-ethyl-4-oxo-2-thiazolidinylidene]methyl]-3-ethyl-, iodide
106276-79-3 Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl ester, reaction products with 2-methyl-1,3-benzenediamine and sodium methoxide
106726-11-8 Neodecanoic acid, neodynium(3+) salt
107630-41-1 Nitric acid, ammonium calcium salt (11:1:5)
107667-02-7 Phophinodithioic acid, bis(2,4,4-trimethylpentyl)-
109037-75-4 Benzene, reaction products with chlorine and sulfur chloride (S2Cl2), hexafluoroantimonates(1-)
114488-10-7 10H-Phenothiazine, 10-[2-[(2S)-1-methyl-2-piperidinyl]ethyl]-2-(methylthio)-
114862-93-0 Methylium, [4-(dimethylamino)phenyl]bis[4-(ethylamino)-3-methylphenyl]-, molybdatephosphate
114887-05-7 Methylium, bis[4-(dimethylamino)phenyl][4-(ethylamino)-3-methylphenyl]-, molybdatephosphate
115017-00-0 10H-Phenothiazine-10-ethanamine, N,N-diethyl-a-methyl-, (-)-
117920-00-0 Amines, C16-22-tert-alkyl, compds. with 2(3H)-benzothiazolethione (1:1)
119040-04-9 Cyclohexanol, 2-methyl(trimethylbicyclo[2.2.1]hept-2-yl)-
119299-02-4 Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, hydroxides
121028-72-6 Aluminum, hydroxybis(1-oxodecyl)-
121028-73-7 Aluminum, dihydroxy(1-oxooctyl)-
121053-36-9 Slimes and Sludges, nickel refining
121053-43-8 Aluminum, dihydroxy(1-oxodecyl)-
121754-48-1 Benzenediazonium, 2-methoxy-4-(phenylamino)-, salt with 3,5-dimethylbenzenemethanesulfonic acid (1:1), reaction products with 1-(methoxymethyl)-4-(4-methylphenoxy)benzene and 1,1′-oxybis[4-(methoxymethyl)benzene]
121754-49-2 2,4-Pentanedione, reaction products with 2-methyl-2-propanol, nonylphenol and tungsten chloride (WCl6)
123774-64-1 Aluminum, (2-ethylhexanoato-O)dihydroxy-
125328-39-4 Amines, N-canola-oil alkyltrimethylenedi-
125328-45-2 Amines, hydrogenated tallow alkyl, distn., residues
125328-62-3 Nitriles, canola-oil
125328-63-4 Nitriles, canola-oil, hydrogenated
125328-86-1 2-Anthracenesulfonic acid, 1-amino-4-[[4-(1,1-dimethylethyl)phenyl]amino]-9,10-dihydro-9,10-dioxo-, monolithium salt
125328-87-2 Benzene, 1-ethyl-2-(2-phenylethyl)-
125328-94-1 Benzene, 1-ethyl-3-(2-phenylethyl)-
125494-53-3 Slags, aluminum refining
125494-54-4 Slimes and Sludges, zinc refining
126820-94-8 Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1+) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes, sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1+) salt
126820-96-0 Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1+) salt, reaction products with sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1+) salt
127032-53-5 (see note 1gg) Protein hydrolyzates, poultry-feather
129618-38-8 Solutions, nickel hydrometallurgical
132373-76-3 2-Naphthalenesulfonic acid, 1,5-bis(1-methylethyl)-, compd. with cyclohexanamine (1:1)
134098-61-6 Benzoic acid, 4-[[[(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]-, 1,1-dimethylethyl ester
143106-84-7 2-Butanone, 4-[[[1,2,3,4,4a,9,10,10a- octahydro-1,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenyl ]methyl](3-oxo-3-phenylpropyl)amino]-, hydrochloride, [1R-(1α,4aα)]-
152923-48-3 (see note 1hh) Amylase, α-, Bacillus amyloliquefaciens
  • Note 3 The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.
  • Note 1a These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1b These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1c These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1d These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1e These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1f These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1g These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1h These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1i These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1j These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1k These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1l These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1m These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1n These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1o These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1p These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1q These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1r These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1s These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1t These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1u These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1v These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1w These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1x These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1y These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1z These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1aa These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1bb These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1cc These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1dd These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1ee These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1ff These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1gg These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.
  • Note 1hh These substances were not identified under subsection 73(1) of CEPA 1999 but were included in this assessment as they were considered as priorities based on other human health concerns.

Masked substances identified as not meeting the criteria under section 64 of CEPA 1999

Confidential accession number (see note 4) Masked name
10003-4 Sulfurized alkyl phenols
10004-5 Maleic acid reaction product with alkyl amine
10034-8 Alkylsalicylic acid, zinc salt
10035-0 Alkylsalicylic acid, zinc salt
10688-5 Alkylsalicylic acid, sodium salt
10701-0 Adipic acid, product with C16C18 alcohols and alkenylsuccinic anhydride
11005-7 Dialkyl(alkyldimethylsiloxy)aluminum
11035-1 Diethanolamine salts of mono- and bis(1H,1H,2H,2H-perfluoroalkyl)phosphates
11043-0 Diethylene triamine distearamide diglycidyl ether
11099-2 2,4-Alkyldione metal salt
11140-7 Substituted phosphinodithioate, zinc salt
11163-3 N,N′,N″-(Tris-(2-hydroxyethyl)-N-(alkyl-1,3-diaminopropane)), molybdate
11166-6 Soybean oil product with sulfur and alkene and organic acid
11192-5 Bisalkoxylated aluminum acetoacetic ester chelate
11193-6 Fatty acids, C18-unsaturated, dimers, distillation, lights, esters with a monohydric alcohol
11194-7 Bis alkoxylated aluminum acetoacetic ester chelate
11199-3 Modified tri-oxyaluminum alkanoate
11204-8 Ethoxylated alkyl alcohol phosphate salts of alkyl octahydrophenanthridine
11444-5 Substituted aromatic diisocyanate - hydroxypropyl methacrylate resin
11500-7 1-Methyl, N-methoxycarbonyl, N′-[2-(perfluoroalkyl)ethoxy]carbonyl-2,4-diaminobenzene
11517-6 Monodithiocarbamate of amines, N-(3-aminopropyl)-N-alkyl-, trimethylenedi-
11519-8 Reaction product of dicyclopentadiene, naphtha, (petroleum), steam cracked middle aromatics, maleic anhydride and terpene
11522-2 Fatty acids, reaction products with maleic anhydride and oleylamine
11523-3 Fatty acids, reaction products with maleic anhydride and oleylamine, ethoxylated
11524-4 Fatty acids, reaction products with maleic anhydride and triethanolamine
11525-5 Fatty acids, maleated
11554-7 Fatty acids, reaction products with maleic anhydride and oleylamine, ethoxylated
11560-4 Diethylene glycol bis(phenyl mercury alkenyl)succinate
11561-5 Diethylene glycol bis(phenyl mercury alkenyl)succinate
11562-6 Diethylene glycol bis(phenyl mercury alkenyl)succinate
11013-6 Polymeric monobutyltin(alkylmercaptoacetate ester), substituted
11060-8 2-Propanol, titanium (4+) salt, polymer with triethoxyvinylsilane;

Note 4 The confidential accession numbers are used to identify substances listed on the confidential portion of the Domestic Substances List (DSL).

[9-1-o]

DEPARTMENT OF INDIAN AFFAIRS AND NORTHERN DEVELOPMENT

AN ACT TO AMEND THE CREE-NASKAPI (OF QUEBEC) ACT

Land set aside as Category IA land for the exclusive use and benefit of the Crees of Oujé-Bougoumou

Under section 32 of An Act to amend the Cree-Naskapi (of Quebec) Act, the Minister of Indian Affairs and Northern Development advises that the land has been set aside by the Governor in Council on May 15, 2014, as Category IA land, for the exclusive use and benefit of the community known as the Crees of Oujé-Bougoumou.

Ottawa, May 15, 2014

BERNARD VALCOURT
Minister of Indian Affairs
and Northern Development

[9-1-o]

DEPARTMENT OF INDUSTRY

BOARDS OF TRADE ACT

Chambre de Commerce de Saint-François

Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated February 5, 2015, has been pleased to change the name of the Chambre de Commerce de Saint-François to the Chambre de Commerce Haut-Madawaska/Chamber of Commerce and to change its boundaries to the regions of the Haut-Madawaska, namely Saint-François, Clair, Lac Baker, Baker-Brook and Saint-Hilaire, upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.

February 11, 2015

VIRGINIE ETHIER
Director

For the Minister of Industry

[9-1-o]

DEPARTMENT OF INDUSTRY

BOARDS OF TRADE ACT

Harrison Hot Springs Chamber of Commerce

Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated November 20, 2014, has been pleased to change the name of Harrison Hot Springs Chamber of Commerce to the Harrison Agassiz Chamber of Commerce and to change its boundaries to the Village of Harrison Hot Springs and the District of Kent upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.

February 18, 2015

VIRGINIE ETHIER
Director

For the Minister of Industry

[9-1-o]

DEPARTMENT OF INDUSTRY

CANADA CORPORATIONS ACT

Application for surrender of charter

Notice is hereby given that, pursuant to the provisions of subsection 32(2) of the Canada Corporations Act, an application for surrender of charter was received from

File No. Name of Company Received
447674-3 AMITA Telemedicine Inc. 12/01/2015

February 18, 2015

VIRGINIE ETHIER
Director

For the Minister of Industry

[9-1-o]

NOTICE OF VACANCY

MILITARY POLICE COMPLAINTS COMMISSION

Chairperson (full-time position)

Salary range: From $141,300 to $166,200
Location: National Capital Region

The Military Police Complaints Commission (MPCC) is a civilian adjudicative police oversight body governed under Part IV of the National Defence Act that reports to Parliament through the Minister of National Defence. The mandate of the MPCC is to monitor and investigate conduct complaints against the military police (MP) in the performance of their policing duties and to investigate interference complaints from the MP against members of the Canadian Armed Forces (CAF) and senior officials of the Department of National Defence (DND). The MPCC may call hearings into a complaint, whereas, it may exercise legislative authority to compel, subpoena and summon witnesses to appear and testify before the MPCC in a public forum.

The MPCC ensures all parties are treated with fairness and objectivity and, when examining complaints, consideration is given to the public interest in the fair and proper enforcement of the law.

As Deputy Head and Chief Executive Officer of the MPCC, the Chairperson is responsible for its efficient and effective operation and its administration. The Chairperson also supervises and directs the work and staff of the Commission.

The ideal candidate would possess a degree from a recognized university in a relevant field of study (such as law, criminology or criminal justice) or possess a related post-graduate degree or an acceptable combination of education, job-related training and/or experience. A degree in law would be considered an asset.

The ideal candidate would have management experience at the executive level in a private or public sector organization, including managing human and financial resources. Experience in the interpretation and application of legislation, regulations and directives is desired. The candidate would also have experience in the development and/or implementation of policy, performance standards and operational procedures. Experience in policing or law enforcement, as well as in the operation and conduct of an adjudicate tribunal, would be considered an asset.

The ideal candidate would have knowledge of the mandate, complaints process and organizational structure of the MPCC, as well as of the National Defence Act and the Canadian Charter of Rights and Freedoms and other relevant legislation. Knowledge of the operations of the federal government, including those related to sound management principles, strategic reporting, accountability and transparency, is sought. He or she would have knowledge of criminal law, administrative law, the principles of natural justice and the rules and practices followed by adjudicative tribunals in Canada. Knowledge of police administration, policing practices and professional standards of conduct would be considered an asset. Knowledge of the CAF, the MP and DND, including their respective mandates and organizational structures, would also be considered an asset.

The ideal candidate would have the ability to provide corporate vision, leadership and strategic direction needed for the Commission to attain its mandate and objectives. He or she would have sound management skills in order to motivate staff and to ensure the Commission adheres to the highest standards of accountability and transparency. Moreover, the Chairperson would have the ability to develop effective working relationships with the Minister, government officials, stakeholders and clients, while maintaining the degree of independence required of an adjudicative body. The ability to conduct fair and efficient adjudicative hearings is desired. This candidate would have the ability to interpret relevant statutes, regulations and policies, and analyze complex situations in order to make equitable and timely decisions and recommendations while also anticipating their short- and long-term consequences. Superior communication skills, both written and oral, are sought.

Along with excellent leadership and superior interpersonal skills, the ideal candidate would possess sound judgement, high ethical standards and integrity, and would be impartial, tactful and diplomatic.

Proficiency in both official languages would be preferred.

The successful candidate must reside in or be willing to relocate to the National Capital Region. He or she must be willing to travel throughout Canada and abroad as required.

An officer, a non-commissioned member of the CAF or an employee of DND is not eligible to be Chairperson of the MPCC.

The Government is committed to ensuring that its appointments are representative of Canada’s regions and official languages, as well as of women, Aboriginal peoples, disabled persons and visible minorities.

The selected candidate must comply with the Ethical and Political Activity Guidelines for Public Office Holders. The Guidelines are available on the Governor in Council Appointments Web site, under “Reference Material,” at www.appointments-nominations.gc.ca/index.asp?lang=eng.

The selected candidate will be subject to the Conflict of Interest Act. Public office holders appointed on a full-time basis must submit to the Office of the Conflict of Interest and Ethics Commissioner, within 60 days of appointment, a confidential report in which they disclose all of their assets, liabilities and outside activities. For more information, please visit the Office of the Conflict of Interest and Ethics Commissioner’s Web site at http://ciec-ccie.gc.ca/Default.aspx?pid=1&lang=en.

This notice has been placed in the Canada Gazette to assist the Governor in Council in identifying qualified candidates for this position. It is not, however, intended to be the sole means of recruitment.

Further details about the MPCC and its activities can be found on its Web site at http://www.mpcc-cppm.gc.ca/index-eng.aspx.

Interested candidates should forward their curriculum vitae by March 16, 2015, to the Assistant Secretary to the Cabinet (Senior Personnel), Privy Council Office, 59 Sparks Street, 1st Floor, Ottawa, Ontario K1A 0A3, 613-957-5006 (fax), GICA-NGEC@pco-bcp.gc.ca (email).

English and French notices of vacancies will be produced in an alternative format upon request. For further information, please contact GICA-NGEC@pco-bcp.gc.ca.

[9-1-o]

OFFICE OF THE SUPERINTENDENT OF FINANCIAL INSTITUTIONS

INSURANCE COMPANIES ACT

Esurance Insurance Company of Canada — Letters patent of incorporation and order to commence and carry on business

Notice is hereby given of the issuance,

  • pursuant to section 22 of the Insurance Companies Act, of letters patent incorporating Esurance Insurance Company of Canada and, in French, Esurance du Canada, Compagnie d’Assurance, effective December 3, 2014; and
  • pursuant to subsection 53(1) of the Insurance Companies Act, of an order authorizing Esurance Insurance Company of Canada, and, in French, Esurance du Canada, Compagnie d’Assurance, to commence and carry on business, effective January 23, 2015.

January 6, 2015

JEREMY RUDIN
Superintendent of Financial Institutions

[9-1-o]

BANK OF CANADA

Statement of financial position as at January 31, 2015

(Millions of dollars) Unaudited

ASSETS

Cash and foreign deposits

 

5.9

Loans and receivables

Securities purchased under resale agreements

 

Advances to members of the Canadian Payments Association

 

Advances to governments

 

Other receivables

5.3

 
   

5.3

Investments

Treasury bills of Canada

20,960.1

 

Government of Canada bonds

72,933.1

 

Other investments

380.9

 
   

94,274.1

Property and equipment

 

288.7

Intangible assets

 

43.1

Other assets

 

186.8

 

94,803.9


LIABILITIES AND EQUITY

Bank notes in circulation

 

67,339.0

Deposits

Government of Canada

24,723.7

 

Members of the Canadian Payments Association

150.5

 

Other deposits

1,547.4

 
   

26,421.6

Liabilities in foreign currencies

Government of Canada

 

Other

 
   

Other liabilities

Securities sold under repurchase agreements

 

Other liabilities

544.1

 
   

544.1

   

94,304.7

Equity

Share capital

5.0

 

Statutory and special reserves

125.0

 

Available-for-sale reserve

369.2

 

Actuarial gains reserve

 

Retained earnings

 
   

499.2

94,803.9

I declare that the foregoing return is correct according to the books of the Bank.

Ottawa, February 13, 2015

CARMEN VIERULA
Chief Financial Officer and Chief Accountant

I declare that the foregoing return is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.

Ottawa, February 13, 2015

STEPHEN S. POLOZ
Governor

[9-1-o]